{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This notebook demonstrates the very small amount of code needed to visualize a BEL network with Jupyter Notebook."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/javascript": [
       "function init_d3_force(d3, graph, chart, width, height, function_colors) {\n",
       "    var focus_node = null;\n",
       "    var highlight_node = null;\n",
       "\n",
       "    // Highlight color variables\n",
       "\n",
       "    // Highlight color of the node boundering\n",
       "    const highlight_node_boundering = \"#4EB2D4\";\n",
       "\n",
       "    // Highlight color of the edge\n",
       "    const highlighted_link_color = \"#4EB2D4\";\n",
       "\n",
       "    // Text highlight color\n",
       "    const highlight_text = \"#4EB2D4\";\n",
       "\n",
       "    // Size when zooming scale\n",
       "    var size = d3.scalePow().exponent(1)\n",
       "        .domain([1, 100])\n",
       "        .range([8, 24]);\n",
       "\n",
       "    // Simulation parameters\n",
       "    const linkDistance = 100;\n",
       "    const fCharge = -1000;\n",
       "    const linkStrength = 0.7;\n",
       "    const collideStrength = 1;\n",
       "\n",
       "    // Simulation defined with variables\n",
       "    var simulation = d3.forceSimulation()\n",
       "        .force(\"link\", d3.forceLink()\n",
       "            .distance(linkDistance)\n",
       "            .strength(linkStrength)\n",
       "        )\n",
       "        .force(\"collide\", d3.forceCollide()\n",
       "            .radius(function (d) {\n",
       "                return d.r + 10\n",
       "            })\n",
       "            .strength(collideStrength)\n",
       "        )\n",
       "        .force(\"charge\", d3.forceManyBody()\n",
       "            .strength(fCharge)\n",
       "        )\n",
       "        .force(\"center\", d3.forceCenter(width / 2, height / 2))\n",
       "        .force(\"y\", d3.forceY(0))\n",
       "        .force(\"x\", d3.forceX(0));\n",
       "\n",
       "    // Pin down functionality\n",
       "    var node_drag = d3.drag()\n",
       "        .on(\"start\", dragstarted)\n",
       "        .on(\"drag\", dragged)\n",
       "        .on(\"end\", dragended);\n",
       "\n",
       "    function dragstarted(d) {\n",
       "        if (!d3.event.active) simulation.alphaTarget(0.3).restart();\n",
       "        d.fx = d.x;\n",
       "        d.fy = d.y;\n",
       "    }\n",
       "\n",
       "    function dragged(d) {\n",
       "        d.fx = d3.event.x;\n",
       "        d.fy = d3.event.y;\n",
       "    }\n",
       "\n",
       "    function dragended(d) {\n",
       "        if (!d3.event.active) simulation.alphaTarget(0);\n",
       "    }\n",
       "\n",
       "    function releasenode(d) {\n",
       "        d.fx = null;\n",
       "        d.fy = null;\n",
       "    }\n",
       "\n",
       "    //END Pin down functionality\n",
       "\n",
       "    const color_circunferencia = \"black\";\n",
       "    const default_link_color = \"#AAAAAA\";\n",
       "    const nominal_base_node_size = 8;\n",
       "\n",
       "    // Normal and highlighted stroke of the links (double the width of the link when highlighted)\n",
       "    const nominal_stroke = 1.5;\n",
       "\n",
       "    // Zoom variables\n",
       "    const min_zoom = 0.1;\n",
       "    const max_zoom = 10;\n",
       "    const border = 1;\n",
       "    const bordercolor = 'black';\n",
       "\n",
       "    var svg = d3.select(chart).append(\"svg\")\n",
       "        .attr(\"width\", width)\n",
       "        .attr(\"height\", height);\n",
       "\n",
       "    // // Create definition for arrowhead.\n",
       "    svg.append(\"defs\").append(\"marker\")\n",
       "        .attr(\"id\", \"arrowhead\")\n",
       "        .attr(\"viewBox\", \"0 -5 10 10\")\n",
       "        .attr(\"refX\", 20)\n",
       "        .attr(\"refY\", 0)\n",
       "        .attr(\"markerUnits\", \"strokeWidth\")\n",
       "        .attr(\"markerWidth\", 6)\n",
       "        .attr(\"markerHeight\", 6)\n",
       "        .attr(\"orient\", \"auto\")\n",
       "        .append(\"path\")\n",
       "        .attr(\"d\", \"M0,-5L10,0L0,5\");\n",
       "\n",
       "    // // Create definition for stub.\n",
       "    svg.append(\"defs\").append(\"marker\")\n",
       "        .attr(\"id\", \"stub\")\n",
       "        .attr(\"viewBox\", \"-1 -5 2 10\")\n",
       "        .attr(\"refX\", 15)\n",
       "        .attr(\"refY\", 0)\n",
       "        .attr(\"markerUnits\", \"strokeWidth\")\n",
       "        .attr(\"markerWidth\", 6)\n",
       "        .attr(\"markerHeight\", 6)\n",
       "        .attr(\"orient\", \"auto\")\n",
       "        .append(\"path\")\n",
       "        .attr(\"d\", \"M 0,0 m -1,-5 L 1,-5 L 1,5 L -1,5 Z\");\n",
       "\n",
       "    // Background\n",
       "    svg.append(\"rect\")\n",
       "        .attr(\"width\", \"100%\")\n",
       "        .attr(\"height\", \"100%\")\n",
       "        .attr(\"fill\", \"#ffffff\")\n",
       "        .style(\"pointer-events\", \"all\")\n",
       "        // Zoom + panning functionality\n",
       "        .call(d3.zoom()\n",
       "            .scaleExtent([min_zoom, max_zoom])\n",
       "            .on(\"zoom\", zoomed))\n",
       "        .on(\"dblclick.zoom\", null);\n",
       "\n",
       "\n",
       "    function zoomed() {\n",
       "        g.attr(\"transform\", d3.event.transform);\n",
       "    }\n",
       "\n",
       "    // g = svg object where the graph will be appended\n",
       "    var g = svg.append(\"g\");\n",
       "\n",
       "    var linkedByIndex = {};\n",
       "    graph.links.forEach(function (d) {\n",
       "        linkedByIndex[d.source + \",\" + d.target] = true;\n",
       "    });\n",
       "\n",
       "    function isConnected(a, b) {\n",
       "        return linkedByIndex[a.index + \",\" + b.index] || linkedByIndex[b.index + \",\" + a.index] || a.index == b.index;\n",
       "    }\n",
       "\n",
       "    function ticked() {\n",
       "        link.attr(\"x1\", function (d) {\n",
       "            return d.source.x;\n",
       "        })\n",
       "            .attr(\"y1\", function (d) {\n",
       "                return d.source.y;\n",
       "            })\n",
       "            .attr(\"x2\", function (d) {\n",
       "                return d.target.x;\n",
       "            })\n",
       "            .attr(\"y2\", function (d) {\n",
       "                return d.target.y;\n",
       "            });\n",
       "\n",
       "        node\n",
       "            .attr(\"transform\", function (d) {\n",
       "                return \"translate(\" + d.x + \", \" + d.y + \")\";\n",
       "            });\n",
       "    }\n",
       "\n",
       "\n",
       "    simulation\n",
       "        .nodes(graph.nodes)\n",
       "        .on(\"tick\", ticked);\n",
       "\n",
       "    simulation.force(\"link\")\n",
       "        .links(graph.links);\n",
       "\n",
       "    // Definition of links nodes text...\n",
       "\n",
       "    var link = g.selectAll(\".link\")\n",
       "        .data(graph.links)\n",
       "        .enter().append(\"line\")\n",
       "        .style(\"stroke-width\", nominal_stroke)\n",
       "        .style(\"stroke\", default_link_color)\n",
       "        .style(\"stroke-dasharray\", function (d) {\n",
       "            if (['decreases', 'directlyDecreases', 'increases', 'directlyIncreases', 'negativeCorrelation',\n",
       "                    'positiveCorrelation'].indexOf(d.relation) >= 0) {\n",
       "                return \"none\"\n",
       "            } else {\n",
       "                return \"4, 4\"\n",
       "            }\n",
       "        })\n",
       "        .attr(\"marker-start\", function (d) {\n",
       "            if ('positiveCorrelation' == d.relation) {\n",
       "                return \"url(#arrowhead)\"\n",
       "            }\n",
       "            else if ('negativeCorrelation' == d.relation) {\n",
       "                return \"url(#stub)\"\n",
       "            }\n",
       "            else {\n",
       "                return \"\"\n",
       "            }\n",
       "        })\n",
       "        .attr(\"marker-end\", function (d) {\n",
       "            if (['increases', 'directlyIncreases', 'positiveCorrelation'].indexOf(d.relation) >= 0) {\n",
       "                return \"url(#arrowhead)\"\n",
       "            } else if (['decreases', 'directlyDecreases', 'negativeCorrelation'].indexOf(d.relation) >= 0) {\n",
       "                return \"url(#stub)\"\n",
       "            } else {\n",
       "                return \"\"\n",
       "            }\n",
       "        });\n",
       "\n",
       "    var node = g.selectAll(\".nodes\")\n",
       "        .data(graph.nodes)\n",
       "        .enter().append(\"g\")\n",
       "        .attr(\"class\", \"node\")\n",
       "        // Next two lines -> Pin down functionality\n",
       "        .on('dblclick', releasenode)\n",
       "        .call(node_drag);\n",
       "\n",
       "    var circle = node.append(\"path\")\n",
       "        .attr(\"d\", d3.symbol()\n",
       "            .size(function (d) {\n",
       "                return Math.PI * Math.pow(size(d.size) || nominal_base_node_size, 2);\n",
       "            })\n",
       "        )\n",
       "        .attr(\"class\", function (d) {\n",
       "            return d.function\n",
       "        })\n",
       "        .style('fill', function (d) {\n",
       "            return function_colors[d.function]\n",
       "        })\n",
       "        .style(\"stroke-width\", nominal_stroke)\n",
       "        .style(\"stroke\", color_circunferencia);\n",
       "\n",
       "    var text = node.append(\"text\")\n",
       "        .attr(\"class\", \"node-name\")\n",
       "        // .attr(\"id\", nodehashes[d])\n",
       "        .attr(\"fill\", \"black\")\n",
       "        .attr(\"dx\", 12)\n",
       "        .attr(\"dy\", \".35em\")\n",
       "        .text(function (d) {\n",
       "            return d.cname\n",
       "        });\n",
       "\n",
       "    // Highlight on mouseenter and back to normal on mouseout\n",
       "    node.on(\"mouseenter\", function (d) {\n",
       "        set_highlight(d);\n",
       "    })\n",
       "        .on(\"mousedown\", function () {\n",
       "            d3.event.stopPropagation();\n",
       "        }).on(\"mouseout\", function () {\n",
       "        exit_highlight();\n",
       "    });\n",
       "\n",
       "    function exit_highlight() {\n",
       "        highlight_node = null;\n",
       "        if (focus_node === null) {\n",
       "            if (highlight_node_boundering != color_circunferencia) {\n",
       "                circle.style(\"stroke\", color_circunferencia);\n",
       "                text.style(\"fill\", \"black\");\n",
       "                link.style(\"stroke\", default_link_color);\n",
       "            }\n",
       "        }\n",
       "    }\n",
       "\n",
       "    function set_highlight(d) {\n",
       "        if (focus_node !== null) d = focus_node;\n",
       "        highlight_node = d;\n",
       "\n",
       "        if (highlight_node_boundering != color_circunferencia) {\n",
       "            circle.style(\"stroke\", function (o) {\n",
       "                return isConnected(d, o) ? highlight_node_boundering : color_circunferencia;\n",
       "            });\n",
       "            text.style(\"fill\", function (o) {\n",
       "                return isConnected(d, o) ? highlight_text : \"black\";\n",
       "            });\n",
       "            link.style(\"stroke\", function (o) {\n",
       "                return o.source.index == d.index || o.target.index == d.index ? highlighted_link_color : default_link_color;\n",
       "            });\n",
       "        }\n",
       "    }\n",
       "\n",
       "\n",
       "    // Freeze the graph when space is pressed\n",
       "    function freezeGraph() {\n",
       "        // Space button Triggers STOP\n",
       "        if (d3.event.keyCode == 32) {\n",
       "            simulation.stop();\n",
       "        }\n",
       "    }\n",
       "\n",
       "    // Call freezeGraph when a key is pressed, freezeGraph checks whether this key is \"Space\" that triggers the freeze\n",
       "    d3.select(window).on(\"keydown\", freezeGraph);\n",
       "}\n",
       "        var chart = \"chmpjqkudvqtxafs\";\n",
       "        var width = 1000;\n",
       "        var height = 650;\n",
       "        var graph = {\"directed\": true, \"multigraph\": true, \"graph\": {\"document_metadata\": {}, \"pybel_version\": \"0.5.10.dev0\", \"namespace_url\": {}, \"namespace_owl\": {}, \"namespace_pattern\": {}, \"annotation_url\": {}, \"annotation_owl\": {}, \"annotation_pattern\": {}, \"annotation_list\": {}}, \"nodes\": [{\"function\": \"Pathology\", \"namespace\": \"MESHD\", \"name\": \"Alzheimer Disease\", \"cname\": \"Alzheimer Disease\", \"id\": [\"Pathology\", \"MESHD\", \"Alzheimer Disease\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"GOBP\", \"name\": \"neuron apoptotic process\", \"cname\": \"neuron apoptotic process\", \"id\": [\"BiologicalProcess\", \"GOBP\", \"neuron apoptotic process\"]}, {\"function\": \"Gene\", \"namespace\": \"HGNC\", \"name\": \"PPP2R1A\", \"description\": \"This gene encodes a constant regulatory subunit of protein phosphatase 2. Protein phosphatase 2 is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. The constant regulatory subunit A serves as a scaffolding molecule to coordinate the assembly of the catalytic subunit and a variable regulatory B subunit. This gene encodes an alpha isoform of the constant regulatory subunit A. Alternatively spliced transcript variants have been described. [provided by RefSeq, Apr 2010]\", \"label\": \"protein phosphatase 2 scaffold subunit Aalpha\", \"cname\": \"PPP2R1A\", \"id\": [\"Gene\", \"HGNC\", \"PPP2R1A\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"PPP2CA\", \"description\": \"This gene encodes the phosphatase 2A catalytic subunit. Protein phosphatase 2A is one of the four major Ser/Thr phosphatases, and it is implicated in the negative control of cell growth and division. It consists of a common heteromeric core enzyme, which is composed of a catalytic subunit and a constant regulatory subunit, that associates with a variety of regulatory subunits. This gene encodes an alpha isoform of the catalytic subunit. [provided by RefSeq, Jul 2008]\", \"label\": \"protein phosphatase 2 catalytic subunit alpha\", \"cname\": \"PPP2CA\", \"id\": [\"Protein\", \"HGNC\", \"PPP2CA\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"DPYSL3\", \"description\": null, \"label\": \"dihydropyrimidinase like 3\", \"cname\": \"DPYSL3\", \"id\": [\"RNA\", \"HGNC\", \"DPYSL3\"]}, {\"function\": \"Abundance\", \"namespace\": \"CHEBI\", \"name\": \"hydrogen peroxide\", \"cname\": \"hydrogen peroxide\", \"id\": [\"Abundance\", \"CHEBI\", \"hydrogen peroxide\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"APC\", \"description\": \"This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jul 2008]\", \"label\": \"APC, WNT signaling pathway regulator\", \"cname\": \"APC\", \"id\": [\"RNA\", \"HGNC\", \"APC\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CDK5\", \"description\": \"This gene encodes a proline-directed serine/threonine kinase that is a member of the cyclin-dependent kinase family of proteins. Unlike other members of the family, the protein encoded by this gene does not directly control cell cycle regulation. Instead the protein, which is predominantly expressed at high levels in mammalian postmitotic central nervous system neurons, functions in diverse processes such as synaptic plasticity and neuronal migration through phosphorylation of proteins required for cytoskeletal organization, endocytosis and exocytosis, and apoptosis. In humans, an allelic variant of the gene that results in undetectable levels of the protein has been associated with lethal autosomal recessive lissencephaly-7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]\", \"label\": \"cyclin dependent kinase 5\", \"cname\": \"CDK5\", \"id\": [\"Protein\", \"HGNC\", \"CDK5\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CTNNBIP1\", \"variants\": [{\"kind\": \"pmod\", \"identifier\": {\"namespace\": \"bel\", \"name\": \"Ph\"}}], \"description\": \"The protein encoded by this gene binds CTNNB1 and prevents interaction between CTNNB1 and TCF family members. The encoded protein is a negative regulator of the Wnt signaling pathway. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]\", \"label\": \"catenin beta interacting protein 1\", \"cname\": \"p(HGNC:CTNNBIP1, pmod(Ph))\", \"id\": [\"Protein\", \"HGNC\", \"CTNNBIP1\", [\"pmod\", [\"bel\", \"Ph\"]]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"GSK3B\", \"description\": \"The protein encoded by this gene is a serine-threonine kinase, belonging to the glycogen synthase kinase subfamily. It is involved in energy metabolism, neuronal cell development, and body pattern formation. Polymorphisms in this gene have been implicated in modifying risk of Parkinson disease, and studies in mice show that overexpression of this gene may be relevant to the pathogenesis of Alzheimer disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]\", \"label\": \"glycogen synthase kinase 3 beta\", \"cname\": \"GSK3B\", \"id\": [\"Protein\", \"HGNC\", \"GSK3B\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CTNNBIP1\", \"description\": \"The protein encoded by this gene binds CTNNB1 and prevents interaction between CTNNB1 and TCF family members. The encoded protein is a negative regulator of the Wnt signaling pathway. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]\", \"label\": \"catenin beta interacting protein 1\", \"cname\": \"CTNNBIP1\", \"id\": [\"Protein\", \"HGNC\", \"CTNNBIP1\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"MESHPP\", \"name\": \"Wnt Signaling Pathway\", \"cname\": \"Wnt Signaling Pathway\", \"id\": [\"BiologicalProcess\", \"MESHPP\", \"Wnt Signaling Pathway\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CTNNB1\", \"variants\": [{\"kind\": \"pmod\", \"identifier\": {\"namespace\": \"bel\", \"name\": \"Ph\"}, \"code\": \"Ser\", \"pos\": 37}], \"description\": \"The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]\", \"label\": \"catenin beta 1\", \"cname\": \"p(HGNC:CTNNB1, pmod(Ph, Ser, 37))\", \"id\": [\"Protein\", \"HGNC\", \"CTNNB1\", [\"pmod\", [\"bel\", \"Ph\"], \"Ser\", 37]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CTNNB1\", \"variants\": [{\"kind\": \"pmod\", \"identifier\": {\"namespace\": \"bel\", \"name\": \"Ph\"}, \"code\": \"Ser\", \"pos\": 33}], \"description\": \"The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]\", \"label\": \"catenin beta 1\", \"cname\": \"p(HGNC:CTNNB1, pmod(Ph, Ser, 33))\", \"id\": [\"Protein\", \"HGNC\", \"CTNNB1\", [\"pmod\", [\"bel\", \"Ph\"], \"Ser\", 33]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"LRP6\", \"variants\": [{\"kind\": \"pmod\", \"identifier\": {\"namespace\": \"bel\", \"name\": \"Ph\"}}], \"description\": \"This gene encodes a member of the low density lipoprotein (LDL) receptor gene family. LDL receptors are transmembrane cell surface proteins involved in receptor-mediated endocytosis of lipoprotein and protein ligands. The protein encoded by this gene functions as a receptor or, with Frizzled, a co-receptor for Wnt and thereby transmits the canonical Wnt/beta-catenin signaling cascade. Through its interaction with the Wnt/beta-catenin signaling cascade this gene plays a role in the regulation of cell differentiation, proliferation, and migration and the development of many cancer types. This protein undergoes gamma-secretase dependent RIP- (regulated intramembrane proteolysis) processing but the precise locations of the cleavage sites have not been determined.[provided by RefSeq, Dec 2009]\", \"label\": \"LDL receptor related protein 6\", \"cname\": \"p(HGNC:LRP6, pmod(Ph))\", \"id\": [\"Protein\", \"HGNC\", \"LRP6\", [\"pmod\", [\"bel\", \"Ph\"]]]}, {\"function\": \"Composite\", \"cname\": \"composite()\", \"id\": [\"Composite\", [\"Protein\", \"HGNC\", \"PSEN1\"], [\"Protein\", \"HGNC\", \"PSEN2\"]]}, {\"function\": \"Protein\", \"namespace\": \"SFAM\", \"name\": \"WNT Family\", \"cname\": \"WNT Family\", \"id\": [\"Protein\", \"SFAM\", \"WNT Family\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"GOBP\", \"name\": \"embryo development\", \"cname\": \"embryo development\", \"id\": [\"BiologicalProcess\", \"GOBP\", \"embryo development\"]}, {\"function\": \"Complex\", \"cname\": \"complex()\", \"id\": [\"Complex\", [\"Protein\", \"HGNC\", \"CTNNBIP1\"], [\"Protein\", \"SFAM\", \"TCF/LEF Family\"]]}, {\"function\": \"Composite\", \"cname\": \"composite()\", \"id\": [\"Composite\", [\"Protein\", \"HGNC\", \"AXIN1\"], [\"Protein\", \"HGNC\", \"AXIN2\"]]}, {\"function\": \"Composite\", \"cname\": \"composite()\", \"id\": [\"Composite\", [\"Protein\", \"HGNC\", \"CSNK1G1\"], [\"Protein\", \"HGNC\", \"CSNK1G3\"]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"AXIN1\", \"description\": \"This gene encodes a cytoplasmic protein which contains a regulation of G-protein signaling (RGS) domain and a dishevelled and axin (DIX) domain. The encoded protein interacts with adenomatosis polyposis coli, catenin beta-1, glycogen synthase kinase 3 beta, protein phosphate 2, and itself. This protein functions as a negative regulator of the wingless-type MMTV integration site family, member 1 (WNT) signaling pathway and can induce apoptosis. The crystal structure of a portion of this protein, alone and in a complex with other proteins, has been resolved. Mutations in this gene have been associated with hepatocellular carcinoma, hepatoblastomas, ovarian endometriod adenocarcinomas, and medullablastomas. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]\", \"label\": \"axin 1\", \"cname\": \"AXIN1\", \"id\": [\"Protein\", \"HGNC\", \"AXIN1\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CTNNB1\", \"variants\": [{\"kind\": \"pmod\", \"identifier\": {\"namespace\": \"bel\", \"name\": \"Ph\"}, \"code\": \"Ser\", \"pos\": 45}], \"description\": \"The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]\", \"label\": \"catenin beta 1\", \"cname\": \"p(HGNC:CTNNB1, pmod(Ph, Ser, 45))\", \"id\": [\"Protein\", \"HGNC\", \"CTNNB1\", [\"pmod\", [\"bel\", \"Ph\"], \"Ser\", 45]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"BTRC\", \"description\": \"This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbws class; in addition to an F-box, this protein contains multiple WD-40 repeats. The encoded protein mediates degradation of CD4 via its interaction with HIV-1 Vpu. It has also been shown to ubiquitinate phosphorylated NFKBIA (nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha), targeting it for degradation and thus activating nuclear factor kappa-B. Alternatively spliced transcript variants have been described. A related pseudogene exists in chromosome 6. [provided by RefSeq, Mar 2012]\", \"label\": \"beta-transducin repeat containing E3 ubiquitin protein ligase\", \"cname\": \"BTRC\", \"id\": [\"Protein\", \"HGNC\", \"BTRC\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"GOBP\", \"name\": \"Notch signaling pathway\", \"cname\": \"Notch signaling pathway\", \"id\": [\"BiologicalProcess\", \"GOBP\", \"Notch signaling pathway\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"GOBP\", \"name\": \"brain development\", \"cname\": \"brain development\", \"id\": [\"BiologicalProcess\", \"GOBP\", \"brain development\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CTNNB1\", \"description\": \"The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]\", \"label\": \"catenin beta 1\", \"cname\": \"CTNNB1\", \"id\": [\"Protein\", \"HGNC\", \"CTNNB1\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"GOBP\", \"name\": \"neurogenesis\", \"cname\": \"neurogenesis\", \"id\": [\"BiologicalProcess\", \"GOBP\", \"neurogenesis\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"GOBP\", \"name\": \"regulation of bone development\", \"cname\": \"regulation of bone development\", \"id\": [\"BiologicalProcess\", \"GOBP\", \"regulation of bone development\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CTNNB1\", \"variants\": [{\"kind\": \"pmod\", \"identifier\": {\"namespace\": \"bel\", \"name\": \"Ub\"}}], \"description\": \"The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]\", \"label\": \"catenin beta 1\", \"cname\": \"p(HGNC:CTNNB1, pmod(Ub))\", \"id\": [\"Protein\", \"HGNC\", \"CTNNB1\", [\"pmod\", [\"bel\", \"Ub\"]]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"DKK1\", \"description\": \"This gene encodes a protein that is a member of the dickkopf family. It is a secreted protein with two cysteine rich regions and is involved in embryonic development through its inhibition of the WNT signaling pathway. Elevated levels of DKK1 in bone marrow plasma and peripheral blood is associated with the presence of osteolytic bone lesions in patients with multiple myeloma. [provided by RefSeq, Jul 2008]\", \"label\": \"dickkopf WNT signaling pathway inhibitor 1\", \"cname\": \"DKK1\", \"id\": [\"Protein\", \"HGNC\", \"DKK1\"]}, {\"function\": \"Gene\", \"namespace\": \"HGNC\", \"name\": \"NAB2\", \"description\": \"This gene encodes a member of the family of NGFI-A binding (NAB) proteins, which function in the nucleus to repress transcription induced by some members of the EGR (early growth response) family of transactivators. NAB proteins can homo- or hetero-multimerize with other EGR or NAB proteins through a conserved N-terminal domain, and repress transcription through two partially redundant C-terminal domains. Transcriptional repression by the encoded protein is mediated in part by interactions with the nucleosome remodeling and deactylase (NuRD) complex. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]\", \"label\": \"NGFI-A binding protein 2\", \"cname\": \"NAB2\", \"id\": [\"Gene\", \"HGNC\", \"NAB2\"]}, {\"function\": \"Gene\", \"namespace\": \"HGNC\", \"name\": \"EGR1\", \"description\": \"The protein encoded by this gene belongs to the EGR family of C2H2-type zinc-finger proteins. It is a nuclear protein and functions as a transcriptional regulator. The products of target genes it activates are required for differentitation and mitogenesis. Studies suggest this is a cancer suppressor gene. [provided by RefSeq, Dec 2014]\", \"label\": \"early growth response 1\", \"cname\": \"EGR1\", \"id\": [\"Gene\", \"HGNC\", \"EGR1\"]}, {\"function\": \"Gene\", \"namespace\": \"HGNC\", \"name\": \"KLF10\", \"description\": \"This gene encodes a member of a family of proteins that feature C2H2-type zinc finger domains. The encoded protein is a transcriptional repressor that acts as an effector of transforming growth factor beta signaling. Activity of this protein may inhibit the growth of cancers, particularly pancreatic cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]\", \"label\": \"Kruppel like factor 10\", \"cname\": \"KLF10\", \"id\": [\"Gene\", \"HGNC\", \"KLF10\"]}, {\"function\": \"Gene\", \"namespace\": \"HGNC\", \"name\": \"FOS\", \"description\": \"The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2.  These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1.  As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation.  In some cases, expression of the FOS gene has also been associated with apoptotic cell death. [provided by RefSeq, Jul 2008]\", \"label\": \"Fos proto-oncogene, AP-1 transcription factor subunit\", \"cname\": \"FOS\", \"id\": [\"Gene\", \"HGNC\", \"FOS\"]}, {\"function\": \"Protein\", \"namespace\": \"SFAM\", \"name\": \"DVL Family\", \"cname\": \"DVL Family\", \"id\": [\"Protein\", \"SFAM\", \"DVL Family\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"MAPT\", \"variants\": [{\"kind\": \"pmod\", \"identifier\": {\"namespace\": \"bel\", \"name\": \"Ph\"}}], \"description\": \"This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]\", \"label\": \"microtubule associated protein tau\", \"cname\": \"p(HGNC:MAPT, pmod(Ph))\", \"id\": [\"Protein\", \"HGNC\", \"MAPT\", [\"pmod\", [\"bel\", \"Ph\"]]]}, {\"function\": \"Abundance\", \"namespace\": \"CHEBI\", \"name\": \"estrogen\", \"cname\": \"estrogen\", \"id\": [\"Abundance\", \"CHEBI\", \"estrogen\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CCND1\", \"description\": \"The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of tumors and may contribute to tumorigenesis. [provided by RefSeq, Jul 2008]\", \"label\": \"cyclin D1\", \"cname\": \"CCND1\", \"id\": [\"Protein\", \"HGNC\", \"CCND1\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"GOBP\", \"name\": \"cell cycle G1/S phase transition\", \"cname\": \"cell cycle G1/S phase transition\", \"id\": [\"BiologicalProcess\", \"GOBP\", \"cell cycle G1/S phase transition\"]}, {\"function\": \"Abundance\", \"namespace\": \"CHEBI\", \"name\": \"vitamin E\", \"cname\": \"vitamin E\", \"id\": [\"Abundance\", \"CHEBI\", \"vitamin E\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"CUL3\", \"description\": \"This gene encodes a member of the cullin protein family. The encoded protein plays a critical role in the polyubiquitination and subsequent degradation of specific protein substrates as the core component and scaffold protein of an E3 ubiquitin ligase complex. Complexes including the encoded protein may also play a role in late endosome maturation. Mutations in this gene are a cause of type 2E pseudohypoaldosteronism. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]\", \"label\": \"cullin 3\", \"cname\": \"CUL3\", \"id\": [\"RNA\", \"HGNC\", \"CUL3\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"CSNK1D\", \"description\": \"This gene is a member of the casein kinase I (CKI) gene family whose members have been implicated in the control of cytoplasmic and nuclear processes, including DNA replication and repair. The encoded protein may also be involved in the regulation of apoptosis, circadian rhythm, microtubule dynamics, chromosome segregation, and p53-mediated effects on growth. The encoded protein is highly similar to the mouse and rat CK1 delta homologs. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2014]\", \"label\": \"casein kinase 1 delta\", \"cname\": \"CSNK1D\", \"id\": [\"RNA\", \"HGNC\", \"CSNK1D\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"SKP1\", \"description\": \"This gene encodes a component of SCF complexes, which are composed of this protein, cullin 1, a ring-box protein, and one member of the F-box family of proteins. This protein binds directly to the F-box motif found in F-box proteins. SCF complexes are involved in the regulated ubiquitination of specific protein substrates, which targets them for degradation by the proteosome. Specific F-box proteins recognize different target protein(s), and many specific SCF substrates have been identified including regulators of cell cycle progression and development. Studies have also characterized the protein as an RNA polymerase II elongation factor. Alternative splicing of this gene results in two transcript variants. A related pseudogene has been identified on chromosome 7. [provided by RefSeq, Jul 2008]\", \"label\": \"S-phase kinase associated protein 1\", \"cname\": \"SKP1\", \"id\": [\"RNA\", \"HGNC\", \"SKP1\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"CSNK1G3\", \"description\": \"This gene encodes a member of a family of serine/threonine protein kinases that phosphorylate caseins and other acidic proteins. A related protein in the African clawed frog participates in the transmission of Wnt/beta-catenin signaling. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]\", \"label\": \"casein kinase 1 gamma 3\", \"cname\": \"CSNK1G3\", \"id\": [\"RNA\", \"HGNC\", \"CSNK1G3\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CSNK1A1\", \"description\": null, \"label\": \"casein kinase 1 alpha 1\", \"cname\": \"CSNK1A1\", \"id\": [\"Protein\", \"HGNC\", \"CSNK1A1\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"APP\", \"variants\": [{\"kind\": \"frag\", \"start\": 672, \"stop\": 713}], \"description\": \"This gene encodes a cell surface receptor and transmembrane precursor protein that is cleaved by secretases to form a number of peptides. Some of these peptides are secreted and can bind to the acetyltransferase complex APBB1/TIP60 to promote transcriptional activation, while others form the protein basis of the amyloid plaques found in the brains of patients with Alzheimer disease. In addition, two of the peptides are antimicrobial peptides, having been shown to have bacteriocidal and antifungal activities. Mutations in this gene have been implicated in autosomal dominant Alzheimer disease and cerebroarterial amyloidosis (cerebral amyloid angiopathy). Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Aug 2014]\", \"label\": \"amyloid beta precursor protein\", \"cname\": \"p(HGNC:APP, frag(672_713))\", \"id\": [\"Protein\", \"HGNC\", \"APP\", [\"frag\", [672, 713]]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"PSEN1\", \"variants\": [{\"kind\": \"hgvs\", \"identifier\": \"p.Met146Val\"}], \"description\": \"Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma-secretase activity or themselves are protease enzymes. Several alternatively spliced transcript variants encoding different isoforms have been identified for this gene, the full-length nature of only some have been determined. [provided by RefSeq, Aug 2008]\", \"label\": \"presenilin 1\", \"cname\": \"p(HGNC:PSEN1, var(p.Met146Val))\", \"id\": [\"Protein\", \"HGNC\", \"PSEN1\", [\"hgvs\", \"p.Met146Val\"]]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"PTS\", \"name\": \"Wnt/beta_catenin pathway\", \"cname\": \"Wnt/beta_catenin pathway\", \"id\": [\"BiologicalProcess\", \"PTS\", \"Wnt/beta_catenin pathway\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"PSEN1\", \"variants\": [{\"kind\": \"hgvs\", \"identifier\": \"p.Leu286Val\"}], \"description\": \"Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma-secretase activity or themselves are protease enzymes. Several alternatively spliced transcript variants encoding different isoforms have been identified for this gene, the full-length nature of only some have been determined. [provided by RefSeq, Aug 2008]\", \"label\": \"presenilin 1\", \"cname\": \"p(HGNC:PSEN1, var(p.Leu286Val))\", \"id\": [\"Protein\", \"HGNC\", \"PSEN1\", [\"hgvs\", \"p.Leu286Val\"]]}, {\"function\": \"Complex\", \"cname\": \"complex()\", \"id\": [\"Complex\", [\"Protein\", \"HGNC\", \"BTRC\"], [\"Protein\", \"HGNC\", \"CTNNBIP1\"]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CTNNBIP1\", \"variants\": [{\"kind\": \"pmod\", \"identifier\": {\"namespace\": \"bel\", \"name\": \"Ub\"}}], \"description\": \"The protein encoded by this gene binds CTNNB1 and prevents interaction between CTNNB1 and TCF family members. The encoded protein is a negative regulator of the Wnt signaling pathway. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]\", \"label\": \"catenin beta interacting protein 1\", \"cname\": \"p(HGNC:CTNNBIP1, pmod(Ub))\", \"id\": [\"Protein\", \"HGNC\", \"CTNNBIP1\", [\"pmod\", [\"bel\", \"Ub\"]]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CSNK1E\", \"description\": \"The protein encoded by this gene is a serine/threonine protein kinase and a member of the casein kinase I protein family, whose members have been implicated in the control of cytoplasmic and nuclear processes, including DNA replication and repair. The encoded protein is found in the cytoplasm as a monomer and can phosphorylate a variety of proteins, including itself. This protein has been shown to phosphorylate period, a circadian rhythm protein. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Feb 2014]\", \"label\": \"casein kinase 1 epsilon\", \"cname\": \"CSNK1E\", \"id\": [\"Protein\", \"HGNC\", \"CSNK1E\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"PSEN2\", \"variants\": [{\"kind\": \"pmod\", \"identifier\": {\"namespace\": \"bel\", \"name\": \"Ph\"}}], \"description\": \"Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1 or PSEN2) or the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor such that, they either directly regulate gamma-secretase activity, or themselves act are protease enzymes. Two alternatively spliced transcript variants encoding different isoforms of PSEN2 have been identified. [provided by RefSeq, Jul 2008]\", \"label\": \"presenilin 2\", \"cname\": \"p(HGNC:PSEN2, pmod(Ph))\", \"id\": [\"Protein\", \"HGNC\", \"PSEN2\", [\"pmod\", [\"bel\", \"Ph\"]]]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CSNK2A1\", \"description\": \"Casein kinase II is a serine/threonine protein kinase that phosphorylates acidic proteins such as casein. It is involved in various cellular processes, including cell cycle control, apoptosis, and circadian rhythm. The kinase exists as a tetramer and is composed of an alpha, an alpha-prime, and two beta subunits. The alpha subunits contain the catalytic activity while the beta subunits undergo autophosphorylation. The protein encoded by this gene represents the alpha subunit. While this gene is found on chromosome 20, a related transcribed pseudogene is found on chromosome 11. Three transcript variants encoding two different proteins have been found for this gene. [provided by RefSeq, Jul 2014]\", \"label\": \"casein kinase 2 alpha 1\", \"cname\": \"CSNK2A1\", \"id\": [\"Protein\", \"HGNC\", \"CSNK2A1\"]}, {\"function\": \"Abundance\", \"namespace\": \"CHEBI\", \"name\": \"curcumin\", \"cname\": \"curcumin\", \"id\": [\"Abundance\", \"CHEBI\", \"curcumin\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"DVL1\", \"description\": \"DVL1, the human homolog of the Drosophila dishevelled gene (dsh) encodes a cytoplasmic phosphoprotein that regulates cell proliferation, acting as a transducer molecule for developmental processes, including segmentation and neuroblast specification. DVL1 is a candidate gene for neuroblastomatous transformation. The Schwartz-Jampel syndrome and Charcot-Marie-Tooth disease type 2A have been mapped to the same region as DVL1. The phenotypes of these diseases may be consistent with defects which might be expected from aberrant expression of a DVL gene during development. [provided by RefSeq, Jul 2008]\", \"label\": \"dishevelled segment polarity protein 1\", \"cname\": \"DVL1\", \"id\": [\"Protein\", \"HGNC\", \"DVL1\"]}, {\"function\": \"Abundance\", \"namespace\": \"CHEBI\", \"name\": \"estradiol\", \"cname\": \"estradiol\", \"id\": [\"Abundance\", \"CHEBI\", \"estradiol\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"PIP5K1B\", \"description\": null, \"label\": \"phosphatidylinositol-4-phosphate 5-kinase type 1 beta\", \"cname\": \"PIP5K1B\", \"id\": [\"RNA\", \"HGNC\", \"PIP5K1B\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"CAV1\", \"description\": \"The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]\", \"label\": \"caveolin 1\", \"cname\": \"CAV1\", \"id\": [\"Protein\", \"HGNC\", \"CAV1\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"RANBP3\", \"description\": \"This gene encodes a protein with a RanBD1 domain that is found in both the nucleus and cytoplasm. This protein plays a role in nuclear export as part of a heteromeric complex. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]\", \"label\": \"RAN binding protein 3\", \"cname\": \"RANBP3\", \"id\": [\"RNA\", \"HGNC\", \"RANBP3\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"APCS\", \"description\": \"The protein encoded by this gene is a glycoprotein, belonging to the pentraxin family of proteins, which has a characteristic pentameric organization. These family members have considerable sequence homology which is thought to be the result of gene duplication. The binding of the encoded protein to proteins in the pathological amyloid cross-beta fold suggests its possible role as a chaperone. This protein is also thought to control the degradation of chromatin. It has been demonstrated that this protein binds to apoptotic cells at an early stage, which raises the possibility that it is involved in dealing with apoptotic cells in vivo. [provided by RefSeq, Sep 2008]\", \"label\": \"amyloid P component, serum\", \"cname\": \"APCS\", \"id\": [\"RNA\", \"HGNC\", \"APCS\"]}, {\"function\": \"Abundance\", \"namespace\": \"CHEBI\", \"name\": \"celecoxib\", \"cname\": \"celecoxib\", \"id\": [\"Abundance\", \"CHEBI\", \"celecoxib\"]}, {\"function\": \"Abundance\", \"namespace\": \"CHEBI\", \"name\": \"mifepristone\", \"cname\": \"mifepristone\", \"id\": [\"Abundance\", \"CHEBI\", \"mifepristone\"]}, {\"function\": \"RNA\", \"namespace\": \"HGNC\", \"name\": \"AXIN2\", \"description\": \"The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair. [provided by RefSeq, Jul 2008]\", \"label\": \"axin 2\", \"cname\": \"AXIN2\", \"id\": [\"RNA\", \"HGNC\", \"AXIN2\"]}, {\"function\": \"Pathology\", \"namespace\": \"MESHD\", \"name\": \"Brain Ischemia\", \"cname\": \"Brain Ischemia\", \"id\": [\"Pathology\", \"MESHD\", \"Brain Ischemia\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"FRZB\", \"description\": \"The protein encoded by this gene is a secreted protein that is involved in the regulation of bone development. Defects in this gene are a cause of female-specific osteoarthritis (OA) susceptibility. [provided by RefSeq, Apr 2010]\", \"label\": \"frizzled-related protein\", \"cname\": \"FRZB\", \"id\": [\"Protein\", \"HGNC\", \"FRZB\"]}, {\"function\": \"Protein\", \"namespace\": \"HGNC\", \"name\": \"WIF1\", \"description\": \"The protein encoded by this gene functions to inhibit WNT proteins, which are extracellular signaling molecules that play a role in embryonic development. This protein contains a WNT inhibitory factor (WIF) domain and five epidermal growth factor (EGF)-like domains, and is thought to be involved in mesoderm segmentation. This gene functions as a tumor suppressor gene, and has been found to be epigenetically silenced in various cancers. [provided by RefSeq, Jun 2010]\", \"label\": \"WNT inhibitory factor 1\", \"cname\": \"WIF1\", \"id\": [\"Protein\", \"HGNC\", \"WIF1\"]}, {\"function\": \"Gene\", \"namespace\": \"HGNC\", \"name\": \"CYLD\", \"description\": \"This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]\", \"label\": \"CYLD lysine 63 deubiquitinase\", \"cname\": \"CYLD\", \"id\": [\"Gene\", \"HGNC\", \"CYLD\"]}, {\"function\": \"miRNA\", \"namespace\": \"HGNC\", \"name\": \"PWAR1\", \"description\": null, \"label\": \"Prader Willi/Angelman region RNA 1\", \"cname\": \"PWAR1\", \"id\": [\"miRNA\", \"HGNC\", \"PWAR1\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"GOBP\", \"name\": \"canonical Wnt signaling pathway\", \"cname\": \"canonical Wnt signaling pathway\", \"id\": [\"BiologicalProcess\", \"GOBP\", \"canonical Wnt signaling pathway\"]}, {\"function\": \"BiologicalProcess\", \"namespace\": \"GOBP\", \"name\": \"beta-amyloid formation\", \"cname\": \"beta-amyloid formation\", \"id\": [\"BiologicalProcess\", \"GOBP\", \"beta-amyloid formation\"]}], \"links\": [{\"relation\": \"association\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5777, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 0, \"target\": 1, \"key\": 2}, {\"relation\": \"association\", \"evidence\": \"In the first stage of this study a total of 152 SNPs were screened (Table S6). All SNPs did not significantly deviate from HardyWeinberg equilibrium proportions in controls, 10 SNPs deviated in cases. 39 SNPs dropped out prior to analysis due to monomorphism (n=8), genotyping failure (n=21), not biallelic (n=2) and a MAF<0.05 (n=8). A total of 113 SNPs were analyzed for association with disease status in the overall sample, and 6 SNPs in 5 different genes showed significant association with disease status under at least one genetic model (Table I). Both SNPs within SOS2 were significantly associated with disease status, with the remaining positive SNPs located within RPS6KA2 (Gene ID 6196), HNF4A (Gene ID 3172), PPP1CC (Gene ID 5501), and PCK1. Additional analysis of the data stratified by APOE genotype provided evidence of association for 15 SNPs in either the APOE 4 positive or APOE 4 negative sample sets (Table I). Two of these SNPs were associated in the overall Stage 1 sample; SNP 139 (HNF4A) and SNP 150 (PCK1), and it was observed that these SNPs had a greater effect when stratified by APOE genotype: OR 0.5 versus 0.63; OR 2.11 versus 1.54, respectively. Two further PCK1 SNPs (SNP 144 and SNP 149) showed marginal association in the APOE 4 positive samples (P=0.07, 0.09). In addition, there was evidence of positive association for both PPAR polymorphisms (SNP 65 and SNP 66) in the APOE 4 positive sample set. Allele 2 of both of these SNPs (G and T, respectively) appeared to protect against disease (OR=0.5, OR=0.45). The result obtained with the major allele of SNP 52 within INSR (Gene ID 3643), allele A, was also suggestive of a protective factor (OR=0.5; APOE 4 negative samples). A further SNP from INSR, SNP 48, showed a trend toward association, but this result was observed in the APOE 4 positive samples (P=0.06). SNP 20 from the ENPP1 gene (Gene ID 5167) showed evidence for association in both the APOE 4 positive and 4 negative samples. A final 7 SNPs showed evidence of association in the APOE 4 positive samples, SNP 34 (INPPL1 Gene ID 3636), SNP 62 (HK2 Gene ID 3099), SNP 93 (NOS3 Gene ID 4846), and in the APOE 4 negative samples, SNP 72 (GC Gene ID 2638), SNP 94 (ADRB3 Gene ID 155), SNP 130 (CETP Gene ID 1071), and SNP 136 (PPP2R1A Gene ID 5518). Following correction using the False Discovery Rate Procedure (FDR) at a variety of levels, however, the majority of these results could be rejected as false discoveries (Table S8).\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of diabetes science and technology\", \"reference\": \"19885299\", \"authors\": [\"de la Monte SM\", \"Wands JR\"], \"date\": \"2008-11-01\", \"title\": \"Alzheimer's disease is type 3 diabetes-evidence reviewed.\", \"lastauthor\": \"Wands JR\", \"volume\": \"2\", \"issue\": \"6\", \"pages\": \"1101-13\", \"firstauthor\": \"de la Monte SM\"}, \"line\": 7447, \"annotations\": {\"Patient\": \"APOE e4 -ve\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 0, \"target\": 2, \"key\": 1}, {\"relation\": \"negativeCorrelation\", \"evidence\": \"Tau is a microtubule-binding protein that ligates tubulin and accounts for the stability of microtubules. If hyperphos phorylated, tau aggregates and interferes with intraneu ronal metabolism and transport lead ing to neurodegeneration [I 02]. Tau phosphorylation state is regulated by site-specific dephosphorylation through certain phosphatases and by kinases phosphorylating tau protein at specific sites. Protein phosphatase 2A (PP2A) is the major phosphatase with 70% tau phosphatase activity in human brains [I 03]. This implies a protective role of PP2A in neurodegeneration which is consistent with the finding that PP2A activity is reduced in AD brains [104, 105]. The phosphorylation of tau is mainly promoted by GSK-3and cyclin-dependent kinase 5 (Cdk5). Besides these kinases, activated c-Jun N-terminal kinases (JNK) and ERK-1 /-2 signaling lead to an increase in tau phosphorylation and th erefore might be of importance in AD pathogenesis. GSK-3is a serine/threonine kinase, modu lated by insulin/IGF-1 signaling. When the IRIIGF-IR path way is activated, GSK-3is phosphorylated by AKT at Scr 9 leading to its inactivation [I 06-109]. However, PP2A dephosphorylates GSK-3(review in [II 0]), which then phosphorylates tau at several sites leading to an equilibrium of phosphorylation and dephosphorylation of tau (Overview : see Fig. 1). Thus, impaired IRIIGF-1 R signaling might lead to hyperphosphory lation of tau protein and an in creased for mation of neurofibrillary tangles.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Current Alzheimer research\", \"reference\": \"19519303\", \"authors\": [\"Freude S\", \"Schilbach K\", \"Schubert M\"], \"date\": \"2009-06-01\", \"title\": \"The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease.\", \"lastauthor\": \"Schubert M\", \"volume\": \"6\", \"issue\": \"3\", \"pages\": \"213-23\", \"firstauthor\": \"Freude S\"}, \"line\": 8429, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"object\": {\"modifier\": \"Activity\"}, \"source\": 0, \"target\": 3, \"key\": 2}, {\"relation\": \"positiveCorrelation\", \"evidence\": \"Several components in the Wnt signaling pathway, including -catenin and glycogen synthase kinase 3 beta, have been implied in AD pathogenesis. Here, mRNA brain levels from five-month-old tg-ArcSwe and nontransgenic mice were compared using Affymetrix microarray analysis. With surprisingly small overall changes, Wnt signaling was the most affected pathway with altered expression of nine genes in tg-ArcSwe mice. When analyzing mRNA levels of these genes in human brain, transcription factor 7-like 2 (TCF7L2) and v-myc myelocytomatosis viral oncogene homolog (MYC), were increased in Alzheimer's disease (AD) (P < .05). Furthermore, no clear differences in TCF7L2 and MYC mRNA were found in brains with frontotemporal lobar degeneration, suggesting that altered regulation of these Wnt-related genes could be specific to AD. Finally, mRNA levels of three neurogenesis markers were analyzed. Increased mRNA levels of dihydropyrimidinase-like 3 were observed in AD brain, suggesting that altered Wnt signaling pathway regulation may signify synaptic rearrangement or neurogenesis.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"International journal of Alzheimer's disease\", \"reference\": \"21234373\", \"authors\": [\"Blom ES\", \"Wang Y\", \"Skoglund L\", \"Hansson AC\", \"Ubaldi M\", \"Lourdusamy A\", \"Sommer WH\", \"Mielke M\", \"Hyman BT\", \"Heilig M\", \"Lannfelt L\", \"Nilsson LN\", \"Ingelsson M\"], \"date\": \"2010-12-22\", \"title\": \"Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain.\", \"lastauthor\": \"Ingelsson M\", \"volume\": \"2011\", \"issue\": \"\", \"pages\": \"936580\", \"firstauthor\": \"Blom ES\"}, \"line\": 12385, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 0, \"target\": 4, \"key\": 2}, {\"relation\": \"association\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5777, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 1, \"target\": 0, \"key\": 2}, {\"relation\": \"association\", \"evidence\": \"In the first stage of this study a total of 152 SNPs were screened (Table S6). All SNPs did not significantly deviate from HardyWeinberg equilibrium proportions in controls, 10 SNPs deviated in cases. 39 SNPs dropped out prior to analysis due to monomorphism (n=8), genotyping failure (n=21), not biallelic (n=2) and a MAF<0.05 (n=8). A total of 113 SNPs were analyzed for association with disease status in the overall sample, and 6 SNPs in 5 different genes showed significant association with disease status under at least one genetic model (Table I). Both SNPs within SOS2 were significantly associated with disease status, with the remaining positive SNPs located within RPS6KA2 (Gene ID 6196), HNF4A (Gene ID 3172), PPP1CC (Gene ID 5501), and PCK1. Additional analysis of the data stratified by APOE genotype provided evidence of association for 15 SNPs in either the APOE 4 positive or APOE 4 negative sample sets (Table I). Two of these SNPs were associated in the overall Stage 1 sample; SNP 139 (HNF4A) and SNP 150 (PCK1), and it was observed that these SNPs had a greater effect when stratified by APOE genotype: OR 0.5 versus 0.63; OR 2.11 versus 1.54, respectively. Two further PCK1 SNPs (SNP 144 and SNP 149) showed marginal association in the APOE 4 positive samples (P=0.07, 0.09). In addition, there was evidence of positive association for both PPAR polymorphisms (SNP 65 and SNP 66) in the APOE 4 positive sample set. Allele 2 of both of these SNPs (G and T, respectively) appeared to protect against disease (OR=0.5, OR=0.45). The result obtained with the major allele of SNP 52 within INSR (Gene ID 3643), allele A, was also suggestive of a protective factor (OR=0.5; APOE 4 negative samples). A further SNP from INSR, SNP 48, showed a trend toward association, but this result was observed in the APOE 4 positive samples (P=0.06). SNP 20 from the ENPP1 gene (Gene ID 5167) showed evidence for association in both the APOE 4 positive and 4 negative samples. A final 7 SNPs showed evidence of association in the APOE 4 positive samples, SNP 34 (INPPL1 Gene ID 3636), SNP 62 (HK2 Gene ID 3099), SNP 93 (NOS3 Gene ID 4846), and in the APOE 4 negative samples, SNP 72 (GC Gene ID 2638), SNP 94 (ADRB3 Gene ID 155), SNP 130 (CETP Gene ID 1071), and SNP 136 (PPP2R1A Gene ID 5518). Following correction using the False Discovery Rate Procedure (FDR) at a variety of levels, however, the majority of these results could be rejected as false discoveries (Table S8).\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of diabetes science and technology\", \"reference\": \"19885299\", \"authors\": [\"de la Monte SM\", \"Wands JR\"], \"date\": \"2008-11-01\", \"title\": \"Alzheimer's disease is type 3 diabetes-evidence reviewed.\", \"lastauthor\": \"Wands JR\", \"volume\": \"2\", \"issue\": \"6\", \"pages\": \"1101-13\", \"firstauthor\": \"de la Monte SM\"}, \"line\": 7447, \"annotations\": {\"Patient\": \"APOE e4 -ve\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 2, \"target\": 0, \"key\": 1}, {\"relation\": \"decreases\", \"evidence\": \"Tau is a microtubule-binding protein that ligates tubulin and accounts for the stability of microtubules. If hyperphos phorylated, tau aggregates and interferes with intraneu ronal metabolism and transport lead ing to neurodegeneration [I 02]. Tau phosphorylation state is regulated by site-specific dephosphorylation through certain phosphatases and by kinases phosphorylating tau protein at specific sites. Protein phosphatase 2A (PP2A) is the major phosphatase with 70% tau phosphatase activity in human brains [I 03]. This implies a protective role of PP2A in neurodegeneration which is consistent with the finding that PP2A activity is reduced in AD brains [104, 105]. The phosphorylation of tau is mainly promoted by GSK-3and cyclin-dependent kinase 5 (Cdk5). Besides these kinases, activated c-Jun N-terminal kinases (JNK) and ERK-1 /-2 signaling lead to an increase in tau phosphorylation and th erefore might be of importance in AD pathogenesis. GSK-3is a serine/threonine kinase, modu lated by insulin/IGF-1 signaling. When the IRIIGF-IR path way is activated, GSK-3is phosphorylated by AKT at Scr 9 leading to its inactivation [I 06-109]. However, PP2A dephosphorylates GSK-3(review in [II 0]), which then phosphorylates tau at several sites leading to an equilibrium of phosphorylation and dephosphorylation of tau (Overview : see Fig. 1). Thus, impaired IRIIGF-1 R signaling might lead to hyperphosphory lation of tau protein and an in creased for mation of neurofibrillary tangles.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Current Alzheimer research\", \"reference\": \"19519303\", \"authors\": [\"Freude S\", \"Schilbach K\", \"Schubert M\"], \"date\": \"2009-06-01\", \"title\": \"The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease.\", \"lastauthor\": \"Schubert M\", \"volume\": \"6\", \"issue\": \"3\", \"pages\": \"213-23\", \"firstauthor\": \"Freude S\"}, \"line\": 8430, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 3, \"target\": 36, \"key\": 4}, {\"relation\": \"negativeCorrelation\", \"evidence\": \"Tau is a microtubule-binding protein that ligates tubulin and accounts for the stability of microtubules. If hyperphos phorylated, tau aggregates and interferes with intraneu ronal metabolism and transport lead ing to neurodegeneration [I 02]. Tau phosphorylation state is regulated by site-specific dephosphorylation through certain phosphatases and by kinases phosphorylating tau protein at specific sites. Protein phosphatase 2A (PP2A) is the major phosphatase with 70% tau phosphatase activity in human brains [I 03]. This implies a protective role of PP2A in neurodegeneration which is consistent with the finding that PP2A activity is reduced in AD brains [104, 105]. The phosphorylation of tau is mainly promoted by GSK-3and cyclin-dependent kinase 5 (Cdk5). Besides these kinases, activated c-Jun N-terminal kinases (JNK) and ERK-1 /-2 signaling lead to an increase in tau phosphorylation and th erefore might be of importance in AD pathogenesis. GSK-3is a serine/threonine kinase, modu lated by insulin/IGF-1 signaling. When the IRIIGF-IR path way is activated, GSK-3is phosphorylated by AKT at Scr 9 leading to its inactivation [I 06-109]. However, PP2A dephosphorylates GSK-3(review in [II 0]), which then phosphorylates tau at several sites leading to an equilibrium of phosphorylation and dephosphorylation of tau (Overview : see Fig. 1). Thus, impaired IRIIGF-1 R signaling might lead to hyperphosphory lation of tau protein and an in creased for mation of neurofibrillary tangles.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Current Alzheimer research\", \"reference\": \"19519303\", \"authors\": [\"Freude S\", \"Schilbach K\", \"Schubert M\"], \"date\": \"2009-06-01\", \"title\": \"The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease.\", \"lastauthor\": \"Schubert M\", \"volume\": \"6\", \"issue\": \"3\", \"pages\": \"213-23\", \"firstauthor\": \"Freude S\"}, \"line\": 8429, \"subject\": {\"modifier\": \"Activity\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 3, \"target\": 0, \"key\": 2}, {\"relation\": \"positiveCorrelation\", \"evidence\": \"Several components in the Wnt signaling pathway, including -catenin and glycogen synthase kinase 3 beta, have been implied in AD pathogenesis. Here, mRNA brain levels from five-month-old tg-ArcSwe and nontransgenic mice were compared using Affymetrix microarray analysis. With surprisingly small overall changes, Wnt signaling was the most affected pathway with altered expression of nine genes in tg-ArcSwe mice. When analyzing mRNA levels of these genes in human brain, transcription factor 7-like 2 (TCF7L2) and v-myc myelocytomatosis viral oncogene homolog (MYC), were increased in Alzheimer's disease (AD) (P < .05). Furthermore, no clear differences in TCF7L2 and MYC mRNA were found in brains with frontotemporal lobar degeneration, suggesting that altered regulation of these Wnt-related genes could be specific to AD. Finally, mRNA levels of three neurogenesis markers were analyzed. Increased mRNA levels of dihydropyrimidinase-like 3 were observed in AD brain, suggesting that altered Wnt signaling pathway regulation may signify synaptic rearrangement or neurogenesis.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"International journal of Alzheimer's disease\", \"reference\": \"21234373\", \"authors\": [\"Blom ES\", \"Wang Y\", \"Skoglund L\", \"Hansson AC\", \"Ubaldi M\", \"Lourdusamy A\", \"Sommer WH\", \"Mielke M\", \"Hyman BT\", \"Heilig M\", \"Lannfelt L\", \"Nilsson LN\", \"Ingelsson M\"], \"date\": \"2010-12-22\", \"title\": \"Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain.\", \"lastauthor\": \"Ingelsson M\", \"volume\": \"2011\", \"issue\": \"\", \"pages\": \"936580\", \"firstauthor\": \"Blom ES\"}, \"line\": 12385, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 4, \"target\": 0, \"key\": 2}, {\"relation\": \"positiveCorrelation\", \"evidence\": \"Several components in the Wnt signaling pathway, including -catenin and glycogen synthase kinase 3 beta, have been implied in AD pathogenesis. Here, mRNA brain levels from five-month-old tg-ArcSwe and nontransgenic mice were compared using Affymetrix microarray analysis. With surprisingly small overall changes, Wnt signaling was the most affected pathway with altered expression of nine genes in tg-ArcSwe mice. When analyzing mRNA levels of these genes in human brain, transcription factor 7-like 2 (TCF7L2) and v-myc myelocytomatosis viral oncogene homolog (MYC), were increased in Alzheimer's disease (AD) (P < .05). Furthermore, no clear differences in TCF7L2 and MYC mRNA were found in brains with frontotemporal lobar degeneration, suggesting that altered regulation of these Wnt-related genes could be specific to AD. Finally, mRNA levels of three neurogenesis markers were analyzed. Increased mRNA levels of dihydropyrimidinase-like 3 were observed in AD brain, suggesting that altered Wnt signaling pathway regulation may signify synaptic rearrangement or neurogenesis.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"International journal of Alzheimer's disease\", \"reference\": \"21234373\", \"authors\": [\"Blom ES\", \"Wang Y\", \"Skoglund L\", \"Hansson AC\", \"Ubaldi M\", \"Lourdusamy A\", \"Sommer WH\", \"Mielke M\", \"Hyman BT\", \"Heilig M\", \"Lannfelt L\", \"Nilsson LN\", \"Ingelsson M\"], \"date\": \"2010-12-22\", \"title\": \"Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain.\", \"lastauthor\": \"Ingelsson M\", \"volume\": \"2011\", \"issue\": \"\", \"pages\": \"936580\", \"firstauthor\": \"Blom ES\"}, \"line\": 12387, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 4, \"target\": 11, \"key\": 2}, {\"relation\": \"decreases\", \"evidence\": \"Hydrogen Peroxide results in decreased expression of APC mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Free radical biology &amp; medicine\", \"reference\": \"12419474\", \"authors\": [\"Weigel AL\", \"Handa JT\", \"Hjelmeland LM\"], \"date\": \"2002-11-15\", \"title\": \"Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells.\", \"lastauthor\": \"Hjelmeland LM\", \"volume\": \"33\", \"issue\": \"10\", \"pages\": \"1419-32\", \"firstauthor\": \"Weigel AL\"}, \"line\": 52021, \"annotations\": {\"Species\": \"9606\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 5, \"target\": 6, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"It was reported that Abeta-catenin interacts with PSs, and that PS1 promotes Abeta-catenin degradation regulating phosphorylation by cyclin-dependent kinase 5 (CDK5) and GSK-3Abeta. Importantly, GSK-3Abeta was implicated in various neurological disorders, including AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1957, \"subject\": {\"modifier\": \"Activity\"}, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 7, \"target\": 8, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1943, \"object\": {\"modifier\": \"Degradation\"}, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 8, \"target\": 10, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1942, \"subject\": {\"modifier\": \"Activity\"}, \"object\": {\"modifier\": \"Activity\", \"effect\": {\"name\": \"phos\", \"namespace\": \"bel\"}}, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 9, \"target\": 10, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"In the absence of an activating signal, phosphorylation of beta-catenin by glycogen synthase kinase 3 (GSK3) acting in conjunction with adenomatous polyposis coli and axin/conductin causes beta-catenin to interact with the beta-transducin repeat-containing protein which results in its ubiquitination and degradation.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Cellular and molecular life sciences : CMLS\", \"reference\": \"11212302\", \"authors\": [\"Novak A\", \"Dedhar S\"], \"date\": \"1999-10-30\", \"title\": \"Signaling through beta-catenin and Lef/Tcf.\", \"lastauthor\": \"Dedhar S\", \"volume\": \"56\", \"issue\": \"5-6\", \"pages\": \"523-37\", \"firstauthor\": \"Novak A\"}, \"line\": 31988, \"subject\": {\"modifier\": \"Activity\", \"effect\": {\"name\": \"kin\", \"namespace\": \"bel\"}}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 9, \"target\": 8, \"key\": 4}, {\"relation\": \"increases\", \"evidence\": \" In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 33912, \"subject\": {\"modifier\": \"Activity\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 9, \"target\": 8, \"key\": 5}, {\"relation\": \"association\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5776, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 9, \"target\": 11, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"Rosiglitazone is a TZD derivative that was recently observed to improve cognition in both APP transgenic mice and AD patients [Watson et al., 2005; Pedersen et al., 2006]. It activates PPAR leading to increased glucose disposal rates [Jung et al., 2005] and is also neuroprotective against Abeta neurotoxicity [Inestrosa et al., 2005]. Neuroprotection may result through modulation of Wnt signaling since an increase in -catenin and inhibition of GSK-3 is observed upon exposure to rosiglitazone [Inestrosa et al., 2005], although a different study has shown that activation of PPAR by a potent ligand leads to -catenin degradation [Liu and Farmer 2004]. Nonetheless, in support of the role for PPAR activation in neuroprotection, PPAR agonists have potent anti-inflammatory effects [Luna-Medina et al., 2005], inhibit microglial activation [Bernardo et al., 2005; Heneka et al., 2005] and have been shown to improve verbal memory in AD patients with T2DM, possibly in a mechanism dependent on PPAR activation . A recent report demonstrates that overexpression of PPAR in cultured cells leads to a dramatic decrease in the production of Abeta, by increasing the rate of APP degradation via ubiquitination [D'Abramo et al., 2005]. This study also showed that by decreasing Abeta secretion, PPAR protects the cells against H2O2-mediated necrosis [D'Abramo et al., 2005].\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of diabetes science and technology\", \"reference\": \"19885299\", \"authors\": [\"de la Monte SM\", \"Wands JR\"], \"date\": \"2008-11-01\", \"title\": \"Alzheimer's disease is type 3 diabetes-evidence reviewed.\", \"lastauthor\": \"Wands JR\", \"volume\": \"2\", \"issue\": \"6\", \"pages\": \"1101-13\", \"firstauthor\": \"de la Monte SM\"}, \"line\": 7502, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 9, \"target\": 11, \"key\": 2}, {\"relation\": \"regulates\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55162, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 9, \"target\": 12, \"key\": 0}, {\"relation\": \"regulates\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55163, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 9, \"target\": 13, \"key\": 0}, {\"relation\": \"regulates\", \"evidence\": \"Wnt signaling requires both Fz and LRP6 (or LRP5), likely through a Wnt-induced Fz-LRP6 complex (Figure 1). Wnt-induced LRP6 phosphorylation is a key event in receptor activation (Tamai et al., 2004). LRP6, LRP5 and Arrow each have five reiterated PPPSPxS motifs (P, proline; S, serine or threonine, x, a variable residue), which are essential for LRP6 function and are each transferrable to a heterologous receptor to result in constitutive -catenin signaling (MacDonald et al., 2008;Tamai et al., 2004;Zeng et al., 2005).\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55176, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 9, \"target\": 14, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \" In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 33913, \"subject\": {\"modifier\": \"Activity\", \"effect\": {\"name\": \"phos\", \"namespace\": \"bel\"}}, \"object\": {\"modifier\": \"Degradation\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 10, \"target\": 10, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5775, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 26, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"Rosiglitazone is a TZD derivative that was recently observed to improve cognition in both APP transgenic mice and AD patients [Watson et al., 2005; Pedersen et al., 2006]. It activates PPAR leading to increased glucose disposal rates [Jung et al., 2005] and is also neuroprotective against Abeta neurotoxicity [Inestrosa et al., 2005]. Neuroprotection may result through modulation of Wnt signaling since an increase in -catenin and inhibition of GSK-3 is observed upon exposure to rosiglitazone [Inestrosa et al., 2005], although a different study has shown that activation of PPAR by a potent ligand leads to -catenin degradation [Liu and Farmer 2004]. Nonetheless, in support of the role for PPAR activation in neuroprotection, PPAR agonists have potent anti-inflammatory effects [Luna-Medina et al., 2005], inhibit microglial activation [Bernardo et al., 2005; Heneka et al., 2005] and have been shown to improve verbal memory in AD patients with T2DM, possibly in a mechanism dependent on PPAR activation . A recent report demonstrates that overexpression of PPAR in cultured cells leads to a dramatic decrease in the production of Abeta, by increasing the rate of APP degradation via ubiquitination [D'Abramo et al., 2005]. This study also showed that by decreasing Abeta secretion, PPAR protects the cells against H2O2-mediated necrosis [D'Abramo et al., 2005].\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of diabetes science and technology\", \"reference\": \"19885299\", \"authors\": [\"de la Monte SM\", \"Wands JR\"], \"date\": \"2008-11-01\", \"title\": \"Alzheimer's disease is type 3 diabetes-evidence reviewed.\", \"lastauthor\": \"Wands JR\", \"volume\": \"2\", \"issue\": \"6\", \"pages\": \"1101-13\", \"firstauthor\": \"de la Monte SM\"}, \"line\": 7499, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 26, \"key\": 3}, {\"relation\": \"association\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5776, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 9, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"Rosiglitazone is a TZD derivative that was recently observed to improve cognition in both APP transgenic mice and AD patients [Watson et al., 2005; Pedersen et al., 2006]. It activates PPAR leading to increased glucose disposal rates [Jung et al., 2005] and is also neuroprotective against Abeta neurotoxicity [Inestrosa et al., 2005]. Neuroprotection may result through modulation of Wnt signaling since an increase in -catenin and inhibition of GSK-3 is observed upon exposure to rosiglitazone [Inestrosa et al., 2005], although a different study has shown that activation of PPAR by a potent ligand leads to -catenin degradation [Liu and Farmer 2004]. Nonetheless, in support of the role for PPAR activation in neuroprotection, PPAR agonists have potent anti-inflammatory effects [Luna-Medina et al., 2005], inhibit microglial activation [Bernardo et al., 2005; Heneka et al., 2005] and have been shown to improve verbal memory in AD patients with T2DM, possibly in a mechanism dependent on PPAR activation . A recent report demonstrates that overexpression of PPAR in cultured cells leads to a dramatic decrease in the production of Abeta, by increasing the rate of APP degradation via ubiquitination [D'Abramo et al., 2005]. This study also showed that by decreasing Abeta secretion, PPAR protects the cells against H2O2-mediated necrosis [D'Abramo et al., 2005].\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of diabetes science and technology\", \"reference\": \"19885299\", \"authors\": [\"de la Monte SM\", \"Wands JR\"], \"date\": \"2008-11-01\", \"title\": \"Alzheimer's disease is type 3 diabetes-evidence reviewed.\", \"lastauthor\": \"Wands JR\", \"volume\": \"2\", \"issue\": \"6\", \"pages\": \"1101-13\", \"firstauthor\": \"de la Monte SM\"}, \"line\": 7502, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 9, \"key\": 2}, {\"relation\": \"increases\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5789, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 25, \"key\": 1}, {\"relation\": \"association\", \"evidence\": \"The Wnt signaling pathway plays a crucial role in the proper development and maintenance of brain and bone structure and function.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Medical hypotheses\", \"reference\": \"26880631\", \"authors\": [\"Guo X\", \"Tang P\", \"Liu P\", \"Liu Y\", \"Chong L\", \"Li R\"], \"date\": \"2016-03-01\", \"title\": \"Dkk1: A promising molecule to connect Alzheimer's disease and osteoporosis.\", \"lastauthor\": \"Li R\", \"volume\": \"88\", \"issue\": \"\", \"pages\": \"30-2\", \"firstauthor\": \"Guo X\"}, \"line\": 55133, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 25, \"key\": 2}, {\"relation\": \"association\", \"evidence\": \"Growing evidence indicates that wingless-type (Wnt) signaling plays an important role in neuronal development, synapse formation and synaptic plasticity.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Physiology &amp; behavior\", \"reference\": \"26032671\", \"authors\": [\"Zhang GL\", \"Zhang J\", \"Li SF\", \"Lei L\", \"Xie HY\", \"Deng F\", \"Feng JC\", \"Qi JS\"], \"date\": \"2015-10-01\", \"title\": \"Wnt-5a prevents A-induced deficits in long-term potentiation and spatial memory in rats.\", \"lastauthor\": \"Qi JS\", \"volume\": \"149\", \"issue\": \"\", \"pages\": \"95-100\", \"firstauthor\": \"Zhang GL\"}, \"line\": 55146, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 25, \"key\": 3}, {\"relation\": \"decreases\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5791, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 0, \"key\": 1}, {\"relation\": \"association\", \"evidence\": \"Several components in the Wnt signaling pathway, including -catenin and glycogen synthase kinase 3 beta, have been implied in AD pathogenesis. Here, mRNA brain levels from five-month-old tg-ArcSwe and nontransgenic mice were compared using Affymetrix microarray analysis. With surprisingly small overall changes, Wnt signaling was the most affected pathway with altered expression of nine genes in tg-ArcSwe mice. When analyzing mRNA levels of these genes in human brain, transcription factor 7-like 2 (TCF7L2) and v-myc myelocytomatosis viral oncogene homolog (MYC), were increased in Alzheimer's disease (AD) (P < .05). Furthermore, no clear differences in TCF7L2 and MYC mRNA were found in brains with frontotemporal lobar degeneration, suggesting that altered regulation of these Wnt-related genes could be specific to AD. Finally, mRNA levels of three neurogenesis markers were analyzed. Increased mRNA levels of dihydropyrimidinase-like 3 were observed in AD brain, suggesting that altered Wnt signaling pathway regulation may signify synaptic rearrangement or neurogenesis.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"International journal of Alzheimer's disease\", \"reference\": \"21234373\", \"authors\": [\"Blom ES\", \"Wang Y\", \"Skoglund L\", \"Hansson AC\", \"Ubaldi M\", \"Lourdusamy A\", \"Sommer WH\", \"Mielke M\", \"Hyman BT\", \"Heilig M\", \"Lannfelt L\", \"Nilsson LN\", \"Ingelsson M\"], \"date\": \"2010-12-22\", \"title\": \"Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain.\", \"lastauthor\": \"Ingelsson M\", \"volume\": \"2011\", \"issue\": \"\", \"pages\": \"936580\", \"firstauthor\": \"Blom ES\"}, \"line\": 12386, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 27, \"key\": 2}, {\"relation\": \"positiveCorrelation\", \"evidence\": \"Several components in the Wnt signaling pathway, including -catenin and glycogen synthase kinase 3 beta, have been implied in AD pathogenesis. Here, mRNA brain levels from five-month-old tg-ArcSwe and nontransgenic mice were compared using Affymetrix microarray analysis. With surprisingly small overall changes, Wnt signaling was the most affected pathway with altered expression of nine genes in tg-ArcSwe mice. When analyzing mRNA levels of these genes in human brain, transcription factor 7-like 2 (TCF7L2) and v-myc myelocytomatosis viral oncogene homolog (MYC), were increased in Alzheimer's disease (AD) (P < .05). Furthermore, no clear differences in TCF7L2 and MYC mRNA were found in brains with frontotemporal lobar degeneration, suggesting that altered regulation of these Wnt-related genes could be specific to AD. Finally, mRNA levels of three neurogenesis markers were analyzed. Increased mRNA levels of dihydropyrimidinase-like 3 were observed in AD brain, suggesting that altered Wnt signaling pathway regulation may signify synaptic rearrangement or neurogenesis.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"International journal of Alzheimer's disease\", \"reference\": \"21234373\", \"authors\": [\"Blom ES\", \"Wang Y\", \"Skoglund L\", \"Hansson AC\", \"Ubaldi M\", \"Lourdusamy A\", \"Sommer WH\", \"Mielke M\", \"Hyman BT\", \"Heilig M\", \"Lannfelt L\", \"Nilsson LN\", \"Ingelsson M\"], \"date\": \"2010-12-22\", \"title\": \"Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain.\", \"lastauthor\": \"Ingelsson M\", \"volume\": \"2011\", \"issue\": \"\", \"pages\": \"936580\", \"firstauthor\": \"Blom ES\"}, \"line\": 12387, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 4, \"key\": 2}, {\"relation\": \"association\", \"evidence\": \"The Wnt signaling pathway plays a crucial role in the proper development and maintenance of brain and bone structure and function.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Medical hypotheses\", \"reference\": \"26880631\", \"authors\": [\"Guo X\", \"Tang P\", \"Liu P\", \"Liu Y\", \"Chong L\", \"Li R\"], \"date\": \"2016-03-01\", \"title\": \"Dkk1: A promising molecule to connect Alzheimer's disease and osteoporosis.\", \"lastauthor\": \"Li R\", \"volume\": \"88\", \"issue\": \"\", \"pages\": \"30-2\", \"firstauthor\": \"Guo X\"}, \"line\": 55134, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 28, \"key\": 0}, {\"relation\": \"regulates\", \"evidence\": \"In the Wnt/-catenin cascade, signaling events converge on the regulation of ubiquitin-mediated degradation of the crucial transcriptional regulator -catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Cell cycle (Georgetown, Tex.)\", \"reference\": \"20930545\", \"authors\": [\"Tauriello DV\", \"Maurice MM\"], \"date\": \"2010-09-15\", \"title\": \"The various roles of ubiquitin in Wnt pathway regulation.\", \"lastauthor\": \"Maurice MM\", \"volume\": \"9\", \"issue\": \"18\", \"pages\": \"3700-9\", \"firstauthor\": \"Tauriello DV\"}, \"line\": 55188, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 29, \"key\": 0}, {\"relation\": \"negativeCorrelation\", \"evidence\": \" Along these lines, one mechanism through which E2 protects the hippocampus from cerebral ischemia is by preventing the post-ischemic elevation of Dkk1, a neurodegenerative factor that serves as an antagonist of the canonical Wnt signaling pathway, and simultaneously inducing pro-survival Wnt/-Catenin signaling in hippocampal neurons.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research\", \"reference\": \"23261660\", \"authors\": [\"Scott EL\", \"Brann DW\"], \"date\": \"2013-06-13\", \"title\": \"Estrogen regulation of Dkk1 and Wnt/-Catenin signaling in neurodegenerative disease.\", \"lastauthor\": \"Brann DW\", \"volume\": \"1514\", \"issue\": \"\", \"pages\": \"63-74\", \"firstauthor\": \"Scott EL\"}, \"line\": 55360, \"annotations\": {\"MeSHAnatomy\": \"Hippocampus\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 30, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"Only one of these common genes, CCND1 (cyclin D1), is a known canonical wnt target,32 with the remaining four encoding transcription factors: EGR1 (early growth response-1), NAB2 (Ngfi-A-binding protein-2), KLF10 (Krppel-like factor-10) and FOS (FBJ murine osteosarcoma viral oncogene homologue). We confirmed the induction of these genes by both A25-35 and by Dkk1 using qRT-PCR\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Molecular psychiatry\", \"reference\": \"23164821\", \"authors\": [\"Killick R\", \"Ribe EM\", \"Al-Shawi R\", \"Malik B\", \"Hooper C\", \"Fernandes C\", \"Dobson R\", \"Nolan PM\", \"Lourdusamy A\", \"Furney S\", \"Lin K\", \"Breen G\", \"Wroe R\", \"To AW\", \"Leroy K\", \"Causevic M\", \"Usardi A\", \"Robinson M\", \"Noble W\", \"Williamson R\", \"Lunnon K\", \"Kellie S\", \"Reynolds CH\", \"Bazenet C\", \"Hodges A\", \"Brion JP\", \"Stephenson J\", \"Simons JP\", \"Lovestone S\"], \"date\": \"2014-01-01\", \"title\": \"Clusterin regulates -amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway.\", \"lastauthor\": \"Lovestone S\", \"volume\": \"19\", \"issue\": \"1\", \"pages\": \"88-98\", \"firstauthor\": \"Killick R\"}, \"line\": 55796, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 31, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"Only one of these common genes, CCND1 (cyclin D1), is a known canonical wnt target,32 with the remaining four encoding transcription factors: EGR1 (early growth response-1), NAB2 (Ngfi-A-binding protein-2), KLF10 (Krppel-like factor-10) and FOS (FBJ murine osteosarcoma viral oncogene homologue). We confirmed the induction of these genes by both A25-35 and by Dkk1 using qRT-PCR\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Molecular psychiatry\", \"reference\": \"23164821\", \"authors\": [\"Killick R\", \"Ribe EM\", \"Al-Shawi R\", \"Malik B\", \"Hooper C\", \"Fernandes C\", \"Dobson R\", \"Nolan PM\", \"Lourdusamy A\", \"Furney S\", \"Lin K\", \"Breen G\", \"Wroe R\", \"To AW\", \"Leroy K\", \"Causevic M\", \"Usardi A\", \"Robinson M\", \"Noble W\", \"Williamson R\", \"Lunnon K\", \"Kellie S\", \"Reynolds CH\", \"Bazenet C\", \"Hodges A\", \"Brion JP\", \"Stephenson J\", \"Simons JP\", \"Lovestone S\"], \"date\": \"2014-01-01\", \"title\": \"Clusterin regulates -amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway.\", \"lastauthor\": \"Lovestone S\", \"volume\": \"19\", \"issue\": \"1\", \"pages\": \"88-98\", \"firstauthor\": \"Killick R\"}, \"line\": 55797, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 32, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"Only one of these common genes, CCND1 (cyclin D1), is a known canonical wnt target,32 with the remaining four encoding transcription factors: EGR1 (early growth response-1), NAB2 (Ngfi-A-binding protein-2), KLF10 (Krppel-like factor-10) and FOS (FBJ murine osteosarcoma viral oncogene homologue). We confirmed the induction of these genes by both A25-35 and by Dkk1 using qRT-PCR\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Molecular psychiatry\", \"reference\": \"23164821\", \"authors\": [\"Killick R\", \"Ribe EM\", \"Al-Shawi R\", \"Malik B\", \"Hooper C\", \"Fernandes C\", \"Dobson R\", \"Nolan PM\", \"Lourdusamy A\", \"Furney S\", \"Lin K\", \"Breen G\", \"Wroe R\", \"To AW\", \"Leroy K\", \"Causevic M\", \"Usardi A\", \"Robinson M\", \"Noble W\", \"Williamson R\", \"Lunnon K\", \"Kellie S\", \"Reynolds CH\", \"Bazenet C\", \"Hodges A\", \"Brion JP\", \"Stephenson J\", \"Simons JP\", \"Lovestone S\"], \"date\": \"2014-01-01\", \"title\": \"Clusterin regulates -amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway.\", \"lastauthor\": \"Lovestone S\", \"volume\": \"19\", \"issue\": \"1\", \"pages\": \"88-98\", \"firstauthor\": \"Killick R\"}, \"line\": 55798, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 33, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"Only one of these common genes, CCND1 (cyclin D1), is a known canonical wnt target,32 with the remaining four encoding transcription factors: EGR1 (early growth response-1), NAB2 (Ngfi-A-binding protein-2), KLF10 (Krppel-like factor-10) and FOS (FBJ murine osteosarcoma viral oncogene homologue). We confirmed the induction of these genes by both A25-35 and by Dkk1 using qRT-PCR\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Molecular psychiatry\", \"reference\": \"23164821\", \"authors\": [\"Killick R\", \"Ribe EM\", \"Al-Shawi R\", \"Malik B\", \"Hooper C\", \"Fernandes C\", \"Dobson R\", \"Nolan PM\", \"Lourdusamy A\", \"Furney S\", \"Lin K\", \"Breen G\", \"Wroe R\", \"To AW\", \"Leroy K\", \"Causevic M\", \"Usardi A\", \"Robinson M\", \"Noble W\", \"Williamson R\", \"Lunnon K\", \"Kellie S\", \"Reynolds CH\", \"Bazenet C\", \"Hodges A\", \"Brion JP\", \"Stephenson J\", \"Simons JP\", \"Lovestone S\"], \"date\": \"2014-01-01\", \"title\": \"Clusterin regulates -amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway.\", \"lastauthor\": \"Lovestone S\", \"volume\": \"19\", \"issue\": \"1\", \"pages\": \"88-98\", \"firstauthor\": \"Killick R\"}, \"line\": 55799, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 11, \"target\": 34, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55158, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 12, \"target\": 21, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55167, \"object\": {\"modifier\": \"Degradation\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 12, \"target\": 26, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55159, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 13, \"target\": 21, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55166, \"object\": {\"modifier\": \"Degradation\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 13, \"target\": 26, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"Besides their involvement in Abeta formation, PSs regulate the cleavage of other signaling receptors and transducers such as Notch-1, ErbB4, DC44, and LDL-receptor-related proteins and cadherins. PSs also affect different other signaling molecules, such as wingless-type MMTV integration site family (Wnt) signal transduction pathway, which is evolutionary conserved and controls many events during the embryogenesis . At cellular level, this pathway regulates morphology, proliferation, and motility of the cell. Wnt signaling pathway plays a central role during tumorigenesis, and the inappropriate activation of this pathway has been observed in several human cancers. It has been shown that Wnt-ligand-mediated signaling leads to the accumulation of cytosolic Abeta-catenin. Cytosolic Abeta-catenin will then translocate into the nucleus to bind to members of the T-cell factor (Tcf)/lymphoid-enhancing factor (Lef) family of DNA-binding proteins leading to the transcription of Wnt target genes.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1926, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 15, \"target\": 16, \"key\": 1}, {\"relation\": \"association\", \"evidence\": \"Besides their involvement in Abeta formation, PSs regulate the cleavage of other signaling receptors and transducers such as Notch-1, ErbB4, DC44, and LDL-receptor-related proteins and cadherins. PSs also affect different other signaling molecules, such as wingless-type MMTV integration site family (Wnt) signal transduction pathway, which is evolutionary conserved and controls many events during the embryogenesis . At cellular level, this pathway regulates morphology, proliferation, and motility of the cell. Wnt signaling pathway plays a central role during tumorigenesis, and the inappropriate activation of this pathway has been observed in several human cancers. It has been shown that Wnt-ligand-mediated signaling leads to the accumulation of cytosolic Abeta-catenin. Cytosolic Abeta-catenin will then translocate into the nucleus to bind to members of the T-cell factor (Tcf)/lymphoid-enhancing factor (Lef) family of DNA-binding proteins leading to the transcription of Wnt target genes.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1926, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 16, \"target\": 15, \"key\": 1}, {\"relation\": \"association\", \"evidence\": \"Besides their involvement in Abeta formation, PSs regulate the cleavage of other signaling receptors and transducers such as Notch-1, ErbB4, DC44, and LDL-receptor-related proteins and cadherins. PSs also affect different other signaling molecules, such as wingless-type MMTV integration site family (Wnt) signal transduction pathway, which is evolutionary conserved and controls many events during the embryogenesis . At cellular level, this pathway regulates morphology, proliferation, and motility of the cell. Wnt signaling pathway plays a central role during tumorigenesis, and the inappropriate activation of this pathway has been observed in several human cancers. It has been shown that Wnt-ligand-mediated signaling leads to the accumulation of cytosolic Abeta-catenin. Cytosolic Abeta-catenin will then translocate into the nucleus to bind to members of the T-cell factor (Tcf)/lymphoid-enhancing factor (Lef) family of DNA-binding proteins leading to the transcription of Wnt target genes.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1927, \"subject\": {\"modifier\": \"Activity\"}, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 16, \"target\": 17, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"Besides their involvement in Abeta formation, PSs regulate the cleavage of other signaling receptors and transducers such as Notch-1, ErbB4, DC44, and LDL-receptor-related proteins and cadherins. PSs also affect different other signaling molecules, such as wingless-type MMTV integration site family (Wnt) signal transduction pathway, which is evolutionary conserved and controls many events during the embryogenesis . At cellular level, this pathway regulates morphology, proliferation, and motility of the cell. Wnt signaling pathway plays a central role during tumorigenesis, and the inappropriate activation of this pathway has been observed in several human cancers. It has been shown that Wnt-ligand-mediated signaling leads to the accumulation of cytosolic Abeta-catenin. Cytosolic Abeta-catenin will then translocate into the nucleus to bind to members of the T-cell factor (Tcf)/lymphoid-enhancing factor (Lef) family of DNA-binding proteins leading to the transcription of Wnt target genes.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1928, \"subject\": {\"modifier\": \"Activity\"}, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 16, \"target\": 10, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"Wnt signaling requires both Fz and LRP6 (or LRP5), likely through a Wnt-induced Fz-LRP6 complex (Figure 1). Wnt-induced LRP6 phosphorylation is a key event in receptor activation (Tamai et al., 2004). LRP6, LRP5 and Arrow each have five reiterated PPPSPxS motifs (P, proline; S, serine or threonine, x, a variable residue), which are essential for LRP6 function and are each transferrable to a heterologous receptor to result in constitutive -catenin signaling (MacDonald et al., 2008;Tamai et al., 2004;Zeng et al., 2005).\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55175, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 16, \"target\": 14, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"Besides their involvement in Abeta formation, PSs regulate the cleavage of other signaling receptors and transducers such as Notch-1, ErbB4, DC44, and LDL-receptor-related proteins and cadherins. PSs also affect different other signaling molecules, such as wingless-type MMTV integration site family (Wnt) signal transduction pathway, which is evolutionary conserved and controls many events during the embryogenesis . At cellular level, this pathway regulates morphology, proliferation, and motility of the cell. Wnt signaling pathway plays a central role during tumorigenesis, and the inappropriate activation of this pathway has been observed in several human cancers. It has been shown that Wnt-ligand-mediated signaling leads to the accumulation of cytosolic Abeta-catenin. Cytosolic Abeta-catenin will then translocate into the nucleus to bind to members of the T-cell factor (Tcf)/lymphoid-enhancing factor (Lef) family of DNA-binding proteins leading to the transcription of Wnt target genes.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1927, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"object\": {\"modifier\": \"Activity\"}, \"source\": 17, \"target\": 16, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"Besides their involvement in Abeta formation, PSs regulate the cleavage of other signaling receptors and transducers such as Notch-1, ErbB4, DC44, and LDL-receptor-related proteins and cadherins. PSs also affect different other signaling molecules, such as wingless-type MMTV integration site family (Wnt) signal transduction pathway, which is evolutionary conserved and controls many events during the embryogenesis . At cellular level, this pathway regulates morphology, proliferation, and motility of the cell. Wnt signaling pathway plays a central role during tumorigenesis, and the inappropriate activation of this pathway has been observed in several human cancers. It has been shown that Wnt-ligand-mediated signaling leads to the accumulation of cytosolic Abeta-catenin. Cytosolic Abeta-catenin will then translocate into the nucleus to bind to members of the T-cell factor (Tcf)/lymphoid-enhancing factor (Lef) family of DNA-binding proteins leading to the transcription of Wnt target genes.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1930, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 18, \"target\": 16, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1938, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\", \"Condition\": \"Normal Healthy State\"}, \"source\": 19, \"target\": 20, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \" In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 33909, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 19, \"target\": 20, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1939, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\", \"Condition\": \"Normal Healthy State\"}, \"source\": 20, \"target\": 8, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \" In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 33910, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 20, \"target\": 8, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1941, \"object\": {\"modifier\": \"Activity\"}, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 20, \"target\": 9, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \" In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 33911, \"object\": {\"modifier\": \"Activity\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 20, \"target\": 9, \"key\": 2}, {\"relation\": \"association\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55157, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 21, \"target\": 22, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55158, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 21, \"target\": 12, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55159, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 21, \"target\": 13, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55157, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 22, \"target\": 21, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55165, \"object\": {\"modifier\": \"Degradation\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 22, \"target\": 26, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1944, \"object\": {\"modifier\": \"Degradation\"}, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 23, \"target\": 10, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 1945, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 23, \"target\": 10, \"key\": 2}, {\"relation\": \"increases\", \"evidence\": \" In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 33914, \"object\": {\"modifier\": \"Degradation\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 23, \"target\": 10, \"key\": 4}, {\"relation\": \"decreases\", \"evidence\": \" In the absence of Wnt ligand, axin recruits CK1 causing the initiation of the Abeta-catenin phosphorylation cascade by glycogen synthase kinase-3 Abeta (GSK-3Abeta). Phosphorylated Abeta-catenin is recognized by Abeta-transducin repeat-containing protein (Abeta-TrCP) and degraded by the proteosome, reducing the level of cytosolic Abeta-catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of toxicology\", \"reference\": \"22496686\", \"authors\": [\"Nizzari M\", \"Thellung S\", \"Corsaro A\", \"Villa V\", \"Pagano A\", \"Porcile C\", \"Russo C\", \"Florio T\"], \"date\": \"2012-01-01\", \"title\": \"Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.\", \"lastauthor\": \"Florio T\", \"volume\": \"2012\", \"issue\": \"\", \"pages\": \"187297\", \"firstauthor\": \"Nizzari M\"}, \"line\": 33915, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 23, \"target\": 10, \"key\": 5}, {\"relation\": \"increases\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5788, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 24, \"target\": 25, \"key\": 1}, {\"relation\": \"decreases\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5790, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 25, \"target\": 1, \"key\": 1}, {\"relation\": \"association\", \"evidence\": \"The Wnt signaling pathway plays a crucial role in the proper development and maintenance of brain and bone structure and function.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Medical hypotheses\", \"reference\": \"26880631\", \"authors\": [\"Guo X\", \"Tang P\", \"Liu P\", \"Liu Y\", \"Chong L\", \"Li R\"], \"date\": \"2016-03-01\", \"title\": \"Dkk1: A promising molecule to connect Alzheimer's disease and osteoporosis.\", \"lastauthor\": \"Li R\", \"volume\": \"88\", \"issue\": \"\", \"pages\": \"30-2\", \"firstauthor\": \"Guo X\"}, \"line\": 55133, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 25, \"target\": 11, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"Growing evidence indicates that wingless-type (Wnt) signaling plays an important role in neuronal development, synapse formation and synaptic plasticity.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Physiology &amp; behavior\", \"reference\": \"26032671\", \"authors\": [\"Zhang GL\", \"Zhang J\", \"Li SF\", \"Lei L\", \"Xie HY\", \"Deng F\", \"Feng JC\", \"Qi JS\"], \"date\": \"2015-10-01\", \"title\": \"Wnt-5a prevents A-induced deficits in long-term potentiation and spatial memory in rats.\", \"lastauthor\": \"Qi JS\", \"volume\": \"149\", \"issue\": \"\", \"pages\": \"95-100\", \"firstauthor\": \"Zhang GL\"}, \"line\": 55146, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 25, \"target\": 11, \"key\": 1}, {\"relation\": \"association\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5775, \"annotations\": {\"Disease\": \"Alzheimer's disease\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 26, \"target\": 11, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"Rosiglitazone is a TZD derivative that was recently observed to improve cognition in both APP transgenic mice and AD patients [Watson et al., 2005; Pedersen et al., 2006]. It activates PPAR leading to increased glucose disposal rates [Jung et al., 2005] and is also neuroprotective against Abeta neurotoxicity [Inestrosa et al., 2005]. Neuroprotection may result through modulation of Wnt signaling since an increase in -catenin and inhibition of GSK-3 is observed upon exposure to rosiglitazone [Inestrosa et al., 2005], although a different study has shown that activation of PPAR by a potent ligand leads to -catenin degradation [Liu and Farmer 2004]. Nonetheless, in support of the role for PPAR activation in neuroprotection, PPAR agonists have potent anti-inflammatory effects [Luna-Medina et al., 2005], inhibit microglial activation [Bernardo et al., 2005; Heneka et al., 2005] and have been shown to improve verbal memory in AD patients with T2DM, possibly in a mechanism dependent on PPAR activation . A recent report demonstrates that overexpression of PPAR in cultured cells leads to a dramatic decrease in the production of Abeta, by increasing the rate of APP degradation via ubiquitination [D'Abramo et al., 2005]. This study also showed that by decreasing Abeta secretion, PPAR protects the cells against H2O2-mediated necrosis [D'Abramo et al., 2005].\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of diabetes science and technology\", \"reference\": \"19885299\", \"authors\": [\"de la Monte SM\", \"Wands JR\"], \"date\": \"2008-11-01\", \"title\": \"Alzheimer's disease is type 3 diabetes-evidence reviewed.\", \"lastauthor\": \"Wands JR\", \"volume\": \"2\", \"issue\": \"6\", \"pages\": \"1101-13\", \"firstauthor\": \"de la Monte SM\"}, \"line\": 7499, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 26, \"target\": 11, \"key\": 3}, {\"relation\": \"association\", \"evidence\": \"Several components in the Wnt signaling pathway, including -catenin and glycogen synthase kinase 3 beta, have been implied in AD pathogenesis. Here, mRNA brain levels from five-month-old tg-ArcSwe and nontransgenic mice were compared using Affymetrix microarray analysis. With surprisingly small overall changes, Wnt signaling was the most affected pathway with altered expression of nine genes in tg-ArcSwe mice. When analyzing mRNA levels of these genes in human brain, transcription factor 7-like 2 (TCF7L2) and v-myc myelocytomatosis viral oncogene homolog (MYC), were increased in Alzheimer's disease (AD) (P < .05). Furthermore, no clear differences in TCF7L2 and MYC mRNA were found in brains with frontotemporal lobar degeneration, suggesting that altered regulation of these Wnt-related genes could be specific to AD. Finally, mRNA levels of three neurogenesis markers were analyzed. Increased mRNA levels of dihydropyrimidinase-like 3 were observed in AD brain, suggesting that altered Wnt signaling pathway regulation may signify synaptic rearrangement or neurogenesis.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"International journal of Alzheimer's disease\", \"reference\": \"21234373\", \"authors\": [\"Blom ES\", \"Wang Y\", \"Skoglund L\", \"Hansson AC\", \"Ubaldi M\", \"Lourdusamy A\", \"Sommer WH\", \"Mielke M\", \"Hyman BT\", \"Heilig M\", \"Lannfelt L\", \"Nilsson LN\", \"Ingelsson M\"], \"date\": \"2010-12-22\", \"title\": \"Increased mRNA Levels of TCF7L2 and MYC of the Wnt Pathway in Tg-ArcSwe Mice and Alzheimer's Disease Brain.\", \"lastauthor\": \"Ingelsson M\", \"volume\": \"2011\", \"issue\": \"\", \"pages\": \"936580\", \"firstauthor\": \"Blom ES\"}, \"line\": 12386, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 27, \"target\": 11, \"key\": 2}, {\"relation\": \"association\", \"evidence\": \"The Wnt signaling pathway plays a crucial role in the proper development and maintenance of brain and bone structure and function.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Medical hypotheses\", \"reference\": \"26880631\", \"authors\": [\"Guo X\", \"Tang P\", \"Liu P\", \"Liu Y\", \"Chong L\", \"Li R\"], \"date\": \"2016-03-01\", \"title\": \"Dkk1: A promising molecule to connect Alzheimer's disease and osteoporosis.\", \"lastauthor\": \"Li R\", \"volume\": \"88\", \"issue\": \"\", \"pages\": \"30-2\", \"firstauthor\": \"Guo X\"}, \"line\": 55134, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 28, \"target\": 11, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"In the Wnt/-catenin cascade, signaling events converge on the regulation of ubiquitin-mediated degradation of the crucial transcriptional regulator -catenin.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Cell cycle (Georgetown, Tex.)\", \"reference\": \"20930545\", \"authors\": [\"Tauriello DV\", \"Maurice MM\"], \"date\": \"2010-09-15\", \"title\": \"The various roles of ubiquitin in Wnt pathway regulation.\", \"lastauthor\": \"Maurice MM\", \"volume\": \"9\", \"issue\": \"18\", \"pages\": \"3700-9\", \"firstauthor\": \"Tauriello DV\"}, \"line\": 55190, \"object\": {\"modifier\": \"Degradation\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 29, \"target\": 26, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \" Along these lines, one mechanism through which E2 protects the hippocampus from cerebral ischemia is by preventing the post-ischemic elevation of Dkk1, a neurodegenerative factor that serves as an antagonist of the canonical Wnt signaling pathway, and simultaneously inducing pro-survival Wnt/-Catenin signaling in hippocampal neurons.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research\", \"reference\": \"23261660\", \"authors\": [\"Scott EL\", \"Brann DW\"], \"date\": \"2013-06-13\", \"title\": \"Estrogen regulation of Dkk1 and Wnt/-Catenin signaling in neurodegenerative disease.\", \"lastauthor\": \"Brann DW\", \"volume\": \"1514\", \"issue\": \"\", \"pages\": \"63-74\", \"firstauthor\": \"Scott EL\"}, \"line\": 55359, \"annotations\": {\"MeSHAnatomy\": \"Hippocampus\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 30, \"target\": 65, \"key\": 1}, {\"relation\": \"negativeCorrelation\", \"evidence\": \" Along these lines, one mechanism through which E2 protects the hippocampus from cerebral ischemia is by preventing the post-ischemic elevation of Dkk1, a neurodegenerative factor that serves as an antagonist of the canonical Wnt signaling pathway, and simultaneously inducing pro-survival Wnt/-Catenin signaling in hippocampal neurons.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research\", \"reference\": \"23261660\", \"authors\": [\"Scott EL\", \"Brann DW\"], \"date\": \"2013-06-13\", \"title\": \"Estrogen regulation of Dkk1 and Wnt/-Catenin signaling in neurodegenerative disease.\", \"lastauthor\": \"Brann DW\", \"volume\": \"1514\", \"issue\": \"\", \"pages\": \"63-74\", \"firstauthor\": \"Scott EL\"}, \"line\": 55360, \"annotations\": {\"MeSHAnatomy\": \"Hippocampus\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 30, \"target\": 11, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \" Along these lines, one mechanism through which E2 protects the hippocampus from cerebral ischemia is by preventing the post-ischemic elevation of Dkk1, a neurodegenerative factor that serves as an antagonist of the canonical Wnt signaling pathway, and simultaneously inducing pro-survival Wnt/-Catenin signaling in hippocampal neurons.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research\", \"reference\": \"23261660\", \"authors\": [\"Scott EL\", \"Brann DW\"], \"date\": \"2013-06-13\", \"title\": \"Estrogen regulation of Dkk1 and Wnt/-Catenin signaling in neurodegenerative disease.\", \"lastauthor\": \"Brann DW\", \"volume\": \"1514\", \"issue\": \"\", \"pages\": \"63-74\", \"firstauthor\": \"Scott EL\"}, \"line\": 55361, \"annotations\": {\"MeSHAnatomy\": \"Hippocampus\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 30, \"target\": 11, \"key\": 3}, {\"relation\": \"increases\", \"evidence\": \"Alzheimer's disease (AD) is a neurodegenerative disease with progressive dementia accompanied by three main structural changes in the brain: diffuse loss of neurons; intracellular protein deposits termed neurofibrillary tangles (NFT) and extracellular protein deposits termed amyloid or senile plaques, surrounded by dystrophic neurites. Recent studies have suggested that the trafficking process of membrane associated proteins is modulated by the FAD-linked presenilin (PS) proteins, and that amyloid beta-peptide deposition may be initiated intracellularly, through the secretory pathway. Current hypotheses concerning presenilin function are based upon its cellular localization and its putative interaction as macromolecular complexes with the cell-adhesion/signaling beta-catenin molecule and the glycogen synthase kinase 3beta (GSK-3beta) enzyme. Developmental studies have shown that PS proteins function as components in the Notch signal transduction cascade and that beta-catenin and GSK-3beta are transducers of the Wnt signaling pathway. Both pathways are thought to have an important role in brain development, and they have been connected through Dishevelled (Dvl) protein, a known transducer of the Wnt signaling pathway. In addition to a review of the current state of research on the subject, we present a cell signaling model in which a sustained loss of function of Wnt signaling components would trigger a series of misrecognition events, determining the onset and development of AD.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research. Brain research reviews\", \"reference\": \"10967351\", \"authors\": [\"De Ferrari GV\", \"Inestrosa NC\"], \"date\": \"2000-08-01\", \"title\": \"Wnt signaling function in Alzheimer's disease.\", \"lastauthor\": \"Inestrosa NC\", \"volume\": \"33\", \"issue\": \"1\", \"pages\": \"1-12\", \"firstauthor\": \"De Ferrari GV\"}, \"line\": 5787, \"annotations\": {\"Condition\": \"Normal Healthy State\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 35, \"target\": 11, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \" Along these lines, one mechanism through which E2 protects the hippocampus from cerebral ischemia is by preventing the post-ischemic elevation of Dkk1, a neurodegenerative factor that serves as an antagonist of the canonical Wnt signaling pathway, and simultaneously inducing pro-survival Wnt/-Catenin signaling in hippocampal neurons.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Brain research\", \"reference\": \"23261660\", \"authors\": [\"Scott EL\", \"Brann DW\"], \"date\": \"2013-06-13\", \"title\": \"Estrogen regulation of Dkk1 and Wnt/-Catenin signaling in neurodegenerative disease.\", \"lastauthor\": \"Brann DW\", \"volume\": \"1514\", \"issue\": \"\", \"pages\": \"63-74\", \"firstauthor\": \"Scott EL\"}, \"line\": 55358, \"annotations\": {\"MeSHAnatomy\": \"Hippocampus\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 37, \"target\": 11, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Nature\", \"reference\": \"1826542\", \"authors\": [\"Motokura T\", \"Bloom T\", \"Kim HG\", \"Jppner H\", \"Ruderman JV\", \"Kronenberg HM\", \"Arnold A\"], \"date\": \"1991-04-11\", \"title\": \"A novel cyclin encoded by a bcl1-linked candidate oncogene.\", \"lastauthor\": \"Arnold A\", \"volume\": \"350\", \"issue\": \"6318\", \"pages\": \"512-5\", \"firstauthor\": \"Motokura T\"}, \"line\": 55494, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 38, \"target\": 39, \"key\": 1}, {\"relation\": \"decreases\", \"evidence\": \"Vitamin E results in decreased expression of CUL3 mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of the National Cancer Institute\", \"reference\": \"19244175\", \"authors\": [\"Tsavachidou D\", \"McDonnell TJ\", \"Wen S\", \"Wang X\", \"Vakar-Lopez F\", \"Pisters LL\", \"Pettaway CA\", \"Wood CG\", \"Do KA\", \"Thall PF\", \"Stephens C\", \"Efstathiou E\", \"Taylor R\", \"Menter DG\", \"Troncoso P\", \"Lippman SM\", \"Logothetis CJ\", \"Kim J\"], \"date\": \"2009-03-04\", \"title\": \"Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.\", \"lastauthor\": \"Kim J\", \"volume\": \"101\", \"issue\": \"5\", \"pages\": \"306-20\", \"firstauthor\": \"Tsavachidou D\"}, \"line\": 46221, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 40, \"target\": 41, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"Vitamin E results in decreased expression of CSNK1D mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of the National Cancer Institute\", \"reference\": \"19244175\", \"authors\": [\"Tsavachidou D\", \"McDonnell TJ\", \"Wen S\", \"Wang X\", \"Vakar-Lopez F\", \"Pisters LL\", \"Pettaway CA\", \"Wood CG\", \"Do KA\", \"Thall PF\", \"Stephens C\", \"Efstathiou E\", \"Taylor R\", \"Menter DG\", \"Troncoso P\", \"Lippman SM\", \"Logothetis CJ\", \"Kim J\"], \"date\": \"2009-03-04\", \"title\": \"Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.\", \"lastauthor\": \"Kim J\", \"volume\": \"101\", \"issue\": \"5\", \"pages\": \"306-20\", \"firstauthor\": \"Tsavachidou D\"}, \"line\": 49086, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 40, \"target\": 42, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"Vitamin E results in increased expression of SKP1A mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of the National Cancer Institute\", \"reference\": \"19244175\", \"authors\": [\"Tsavachidou D\", \"McDonnell TJ\", \"Wen S\", \"Wang X\", \"Vakar-Lopez F\", \"Pisters LL\", \"Pettaway CA\", \"Wood CG\", \"Do KA\", \"Thall PF\", \"Stephens C\", \"Efstathiou E\", \"Taylor R\", \"Menter DG\", \"Troncoso P\", \"Lippman SM\", \"Logothetis CJ\", \"Kim J\"], \"date\": \"2009-03-04\", \"title\": \"Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.\", \"lastauthor\": \"Kim J\", \"volume\": \"101\", \"issue\": \"5\", \"pages\": \"306-20\", \"firstauthor\": \"Tsavachidou D\"}, \"line\": 50916, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 40, \"target\": 43, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"Vitamin E results in decreased expression of CSNK1G3 mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of the National Cancer Institute\", \"reference\": \"19244175\", \"authors\": [\"Tsavachidou D\", \"McDonnell TJ\", \"Wen S\", \"Wang X\", \"Vakar-Lopez F\", \"Pisters LL\", \"Pettaway CA\", \"Wood CG\", \"Do KA\", \"Thall PF\", \"Stephens C\", \"Efstathiou E\", \"Taylor R\", \"Menter DG\", \"Troncoso P\", \"Lippman SM\", \"Logothetis CJ\", \"Kim J\"], \"date\": \"2009-03-04\", \"title\": \"Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.\", \"lastauthor\": \"Kim J\", \"volume\": \"101\", \"issue\": \"5\", \"pages\": \"306-20\", \"firstauthor\": \"Tsavachidou D\"}, \"line\": 53043, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 40, \"target\": 44, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \" Overexpression of constitutively active CK1epsilon, one of the CK1 isoforms expressed in brain, leads to an increase in Abeta peptide production. \", \"citation\": {\"type\": \"PubMed\", \"name\": \"Proceedings of the National Academy of Sciences of the United States of America\", \"reference\": \"17360493\", \"authors\": [\"Flajolet M\", \"He G\", \"Heiman M\", \"Lin A\", \"Nairn AC\", \"Greengard P\"], \"date\": \"2007-03-06\", \"title\": \"Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I.\", \"lastauthor\": \"Greengard P\", \"volume\": \"104\", \"issue\": \"10\", \"pages\": \"4159-64\", \"firstauthor\": \"Flajolet M\"}, \"line\": 25535, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 45, \"target\": 46, \"key\": 0}, {\"relation\": \"regulates\", \"evidence\": \"The scaffolding protein Axin uses separate domains to interact with GSK3, CK1, and -catenin and coordinates sequential phosphorylation of -catenin at serine 45 by CK1 and then at threonine 41, serine 37 and serine 33 by GSK3 (Kimelman and Xu, 2006). -catenin phosphorylation at serine 33 and 37 creates a binding site for the E3 ubiquitin ligase -Trcp, leading to -catenin ubiquitination and degradation\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55161, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 45, \"target\": 22, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"In addition, disease-causing mutant PS-1 (M146V and L286V) enhanced delta-catenin processing,\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Biochemical and biophysical research communications\", \"reference\": \"17097608\", \"authors\": [\"Kim JS\", \"Bareiss S\", \"Kim KK\", \"Tatum R\", \"Han JR\", \"Jin YH\", \"Kim H\", \"Lu Q\", \"Kim K\"], \"date\": \"2006-12-29\", \"title\": \"Presenilin-1 inhibits delta-catenin-induced cellular branching and promotes delta-catenin processing and turnover.\", \"lastauthor\": \"Kim K\", \"volume\": \"351\", \"issue\": \"4\", \"pages\": \"903-8\", \"firstauthor\": \"Kim JS\"}, \"line\": 28630, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 47, \"target\": 48, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"In addition, disease-causing mutant PS-1 (M146V and L286V) enhanced delta-catenin processing,\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Biochemical and biophysical research communications\", \"reference\": \"17097608\", \"authors\": [\"Kim JS\", \"Bareiss S\", \"Kim KK\", \"Tatum R\", \"Han JR\", \"Jin YH\", \"Kim H\", \"Lu Q\", \"Kim K\"], \"date\": \"2006-12-29\", \"title\": \"Presenilin-1 inhibits delta-catenin-induced cellular branching and promotes delta-catenin processing and turnover.\", \"lastauthor\": \"Kim K\", \"volume\": \"351\", \"issue\": \"4\", \"pages\": \"903-8\", \"firstauthor\": \"Kim JS\"}, \"line\": 28631, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 49, \"target\": 48, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"In the absence of an activating signal, phosphorylation of beta-catenin by glycogen synthase kinase 3 (GSK3) acting in conjunction with adenomatous polyposis coli and axin/conductin causes beta-catenin to interact with the beta-transducin repeat-containing protein which results in its ubiquitination and degradation.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Cellular and molecular life sciences : CMLS\", \"reference\": \"11212302\", \"authors\": [\"Novak A\", \"Dedhar S\"], \"date\": \"1999-10-30\", \"title\": \"Signaling through beta-catenin and Lef/Tcf.\", \"lastauthor\": \"Dedhar S\", \"volume\": \"56\", \"issue\": \"5-6\", \"pages\": \"523-37\", \"firstauthor\": \"Novak A\"}, \"line\": 31991, \"object\": {\"modifier\": \"Degradation\"}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 50, \"target\": 10, \"key\": 3}, {\"relation\": \"increases\", \"evidence\": \"In the absence of an activating signal, phosphorylation of beta-catenin by glycogen synthase kinase 3 (GSK3) acting in conjunction with adenomatous polyposis coli and axin/conductin causes beta-catenin to interact with the beta-transducin repeat-containing protein which results in its ubiquitination and degradation.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Cellular and molecular life sciences : CMLS\", \"reference\": \"11212302\", \"authors\": [\"Novak A\", \"Dedhar S\"], \"date\": \"1999-10-30\", \"title\": \"Signaling through beta-catenin and Lef/Tcf.\", \"lastauthor\": \"Dedhar S\", \"volume\": \"56\", \"issue\": \"5-6\", \"pages\": \"523-37\", \"firstauthor\": \"Novak A\"}, \"line\": 31990, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 50, \"target\": 51, \"key\": 2}, {\"relation\": \"increases\", \"evidence\": \"casein kinase (CK)-1 and CK-2 were shown to phosphorylate the N terminus of PS-2 in vitro.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Molecular medicine (Cambridge, Mass.)\", \"reference\": \"8972483\", \"authors\": [\"Walter J\", \"Capell A\", \"Grnberg J\", \"Pesold B\", \"Schindzielorz A\", \"Prior R\", \"Podlisny MB\", \"Fraser P\", \"Hyslop PS\", \"Selkoe DJ\", \"Haass C\"], \"date\": \"1996-11-01\", \"title\": \"The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum.\", \"lastauthor\": \"Haass C\", \"volume\": \"2\", \"issue\": \"6\", \"pages\": \"673-91\", \"firstauthor\": \"Walter J\"}, \"line\": 32388, \"subject\": {\"modifier\": \"Activity\", \"effect\": {\"name\": \"kin\", \"namespace\": \"bel\"}}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 52, \"target\": 53, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"casein kinase (CK)-1 and CK-2 were shown to phosphorylate the N terminus of PS-2 in vitro.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Molecular medicine (Cambridge, Mass.)\", \"reference\": \"8972483\", \"authors\": [\"Walter J\", \"Capell A\", \"Grnberg J\", \"Pesold B\", \"Schindzielorz A\", \"Prior R\", \"Podlisny MB\", \"Fraser P\", \"Hyslop PS\", \"Selkoe DJ\", \"Haass C\"], \"date\": \"1996-11-01\", \"title\": \"The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum.\", \"lastauthor\": \"Haass C\", \"volume\": \"2\", \"issue\": \"6\", \"pages\": \"673-91\", \"firstauthor\": \"Walter J\"}, \"line\": 32389, \"subject\": {\"modifier\": \"Activity\", \"effect\": {\"name\": \"kin\", \"namespace\": \"bel\"}}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 54, \"target\": 53, \"key\": 1}, {\"relation\": \"decreases\", \"evidence\": \"Curcumin results in decreased expression of DVL1 protein\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Chemico-biological interactions\", \"reference\": \"19573523\", \"authors\": [\"Prasad CP\", \"Rath G\", \"Mathur S\", \"Bhatnagar D\", \"Ralhan R\"], \"date\": \"2009-10-07\", \"title\": \"Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.\", \"lastauthor\": \"Ralhan R\", \"volume\": \"181\", \"issue\": \"2\", \"pages\": \"263-71\", \"firstauthor\": \"Prasad CP\"}, \"line\": 49155, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 55, \"target\": 56, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"Curcumin results in decreased expression of APC mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Molecular cancer therapeutics\", \"reference\": \"15713895\", \"authors\": [\"Yan C\", \"Jamaluddin MS\", \"Aggarwal B\", \"Myers J\", \"Boyd DD\"], \"date\": \"2005-02-01\", \"title\": \"Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin.\", \"lastauthor\": \"Boyd DD\", \"volume\": \"4\", \"issue\": \"2\", \"pages\": \"233-41\", \"firstauthor\": \"Yan C\"}, \"line\": 51999, \"annotations\": {\"Species\": \"9606\", \"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 55, \"target\": 6, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"Curcumin nanoparticles increase neuronal differentiation by activating the Wnt/-catenin pathway, involved in regulation of neurogenesis. These nanoparticles caused enhanced nuclear translocation of -catenin, decreased GSK-3 levels, and increased promoter activity of the TCF/LEF and cyclin-D1.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"ACS nano\", \"reference\": \"24467380\", \"authors\": [\"Tiwari SK\", \"Agarwal S\", \"Seth B\", \"Yadav A\", \"Nair S\", \"Bhatnagar P\", \"Karmakar M\", \"Kumari M\", \"Chauhan LK\", \"Patel DK\", \"Srivastava V\", \"Singh D\", \"Gupta SK\", \"Tripathi A\", \"Chaturvedi RK\", \"Gupta KC\"], \"date\": \"2014-01-28\", \"title\": \"Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/-catenin pathway.\", \"lastauthor\": \"Gupta KC\", \"volume\": \"8\", \"issue\": \"1\", \"pages\": \"76-103\", \"firstauthor\": \"Tiwari SK\"}, \"line\": 55519, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 55, \"target\": 11, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"Curcumin nanoparticles increase neuronal differentiation by activating the Wnt/-catenin pathway, involved in regulation of neurogenesis. These nanoparticles caused enhanced nuclear translocation of -catenin, decreased GSK-3 levels, and increased promoter activity of the TCF/LEF and cyclin-D1.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"ACS nano\", \"reference\": \"24467380\", \"authors\": [\"Tiwari SK\", \"Agarwal S\", \"Seth B\", \"Yadav A\", \"Nair S\", \"Bhatnagar P\", \"Karmakar M\", \"Kumari M\", \"Chauhan LK\", \"Patel DK\", \"Srivastava V\", \"Singh D\", \"Gupta SK\", \"Tripathi A\", \"Chaturvedi RK\", \"Gupta KC\"], \"date\": \"2014-01-28\", \"title\": \"Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/-catenin pathway.\", \"lastauthor\": \"Gupta KC\", \"volume\": \"8\", \"issue\": \"1\", \"pages\": \"76-103\", \"firstauthor\": \"Tiwari SK\"}, \"line\": 55520, \"object\": {\"modifier\": \"Activity\", \"effect\": {\"name\": \"tscript\", \"namespace\": \"bel\"}}, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 55, \"target\": 38, \"key\": 1}, {\"relation\": \"increases\", \"evidence\": \"[Estradiol co-treated with Progesterone] results in increased expression of PIP5K1B mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Molecular psychiatry\", \"reference\": \"19687787\", \"authors\": [\"Bethea CL\", \"Reddy AP\"], \"date\": \"2010-10-01\", \"title\": \"Effect of ovarian hormones on genes promoting dendritic spines in laser-captured serotonin neurons from macaques.\", \"lastauthor\": \"Reddy AP\", \"volume\": \"15\", \"issue\": \"10\", \"pages\": \"1034-44\", \"firstauthor\": \"Bethea CL\"}, \"line\": 46637, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 57, \"target\": 58, \"key\": 1}, {\"relation\": \"association\", \"evidence\": \"Estradiol inhibits the reaction [ESR2 protein binds to CAV1 protein]\", \"citation\": {\"type\": \"PubMed\", \"name\": \"FASEB journal : official publication of the Federation of American Societies for Experimental Biology\", \"reference\": \"18296501\", \"authors\": [\"Klinge CM\", \"Wickramasinghe NS\", \"Ivanova MM\", \"Dougherty SM\"], \"date\": \"2008-07-01\", \"title\": \"Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells.\", \"lastauthor\": \"Dougherty SM\", \"volume\": \"22\", \"issue\": \"7\", \"pages\": \"2185-97\", \"firstauthor\": \"Klinge CM\"}, \"line\": 49662, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 57, \"target\": 59, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"Estradiol results in decreased expression of RANBP3 mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Journal of the Society for Gynecologic Investigation\", \"reference\": \"16202921\", \"authors\": [\"Gielen SC\", \"Burger CW\", \"Khne LC\", \"Hanifi-Moghaddam P\", \"Blok LJ\"], \"date\": \"2005-10-01\", \"title\": \"Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.\", \"lastauthor\": \"Blok LJ\", \"volume\": \"12\", \"issue\": \"7\", \"pages\": \"e55-67\", \"firstauthor\": \"Gielen SC\"}, \"line\": 50086, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 57, \"target\": 60, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"Estradiol results in decreased expression of APCS mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Toxicological sciences : an official journal of the Society of Toxicology\", \"reference\": \"20106945\", \"authors\": [\"Jennen DG\", \"Magkoufopoulou C\", \"Ketelslegers HB\", \"van Herwijnen MH\", \"Kleinjans JC\", \"van Delft JH\"], \"date\": \"2010-05-01\", \"title\": \"Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.\", \"lastauthor\": \"van Delft JH\", \"volume\": \"115\", \"issue\": \"1\", \"pages\": \"66-79\", \"firstauthor\": \"Jennen DG\"}, \"line\": 52010, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 57, \"target\": 61, \"key\": 0}, {\"relation\": \"association\", \"evidence\": \"Estradiol inhibits the reaction [ESR2 protein binds to CAV1 protein]\", \"citation\": {\"type\": \"PubMed\", \"name\": \"FASEB journal : official publication of the Federation of American Societies for Experimental Biology\", \"reference\": \"18296501\", \"authors\": [\"Klinge CM\", \"Wickramasinghe NS\", \"Ivanova MM\", \"Dougherty SM\"], \"date\": \"2008-07-01\", \"title\": \"Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells.\", \"lastauthor\": \"Dougherty SM\", \"volume\": \"22\", \"issue\": \"7\", \"pages\": \"2185-97\", \"firstauthor\": \"Klinge CM\"}, \"line\": 49662, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 59, \"target\": 57, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"celecoxib results in increased expression of CAV1 protein\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Mechanisms of ageing and development\", \"reference\": \"18848576\", \"authors\": [\"Kim SR\", \"Park JH\", \"Lee ME\", \"Park JS\", \"Park SC\", \"Han JA\"], \"date\": \"2008-12-01\", \"title\": \"Selective COX-2 inhibitors modulate cellular senescence in human dermal fibroblasts in a catalytic activity-independent manner.\", \"lastauthor\": \"Han JA\", \"volume\": \"129\", \"issue\": \"12\", \"pages\": \"706-13\", \"firstauthor\": \"Kim SR\"}, \"line\": 47016, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 62, \"target\": 59, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"Mifepristone results in increased expression of AXIN2 mRNA\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Molecular human reproduction\", \"reference\": \"17584828\", \"authors\": [\"Catalano RD\", \"Critchley HO\", \"Heikinheimo O\", \"Baird DT\", \"Hapangama D\", \"Sherwin JR\", \"Charnock-Jones DS\", \"Smith SK\", \"Sharkey AM\"], \"date\": \"2007-09-01\", \"title\": \"Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium.\", \"lastauthor\": \"Sharkey AM\", \"volume\": \"13\", \"issue\": \"9\", \"pages\": \"641-54\", \"firstauthor\": \"Catalano RD\"}, \"line\": 52924, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 63, \"target\": 64, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"Several secreted protein families antagonize or modulate Wnt/-catenin signaling. sFRPs (secreted Frizzled related proteins), and WIF (Wnt inhibitory protein) bind to Wnt, and in the case of sFRPs, also to Fz,and thereby function as Wnt antagonists for both -catenin and non-canonical signaling\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55112, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\", \"Condition\": \"Normal Healthy State\"}, \"source\": 66, \"target\": 11, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"Several secreted protein families antagonize or modulate Wnt/-catenin signaling. sFRPs (secreted Frizzled related proteins), and WIF (Wnt inhibitory protein) bind to Wnt, and in the case of sFRPs, also to Fz,and thereby function as Wnt antagonists for both -catenin and non-canonical signaling\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"19619488\", \"authors\": [\"MacDonald BT\", \"Tamai K\", \"He X\"], \"date\": \"2009-07-01\", \"title\": \"Wnt/beta-catenin signaling: components, mechanisms, and diseases.\", \"lastauthor\": \"He X\", \"volume\": \"17\", \"issue\": \"1\", \"pages\": \"9-26\", \"firstauthor\": \"MacDonald BT\"}, \"line\": 55113, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\", \"Condition\": \"Normal Healthy State\"}, \"source\": 67, \"target\": 11, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"A positive role of K63-linked ubiquitylation was recently uncovered by the identification of the DUB enzyme and tumor suppressor CYLD as a negative regulator of upstream Wnt/-catenin signaling.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Cell cycle (Georgetown, Tex.)\", \"reference\": \"20930545\", \"authors\": [\"Tauriello DV\", \"Maurice MM\"], \"date\": \"2010-09-15\", \"title\": \"The various roles of ubiquitin in Wnt pathway regulation.\", \"lastauthor\": \"Maurice MM\", \"volume\": \"9\", \"issue\": \"18\", \"pages\": \"3700-9\", \"firstauthor\": \"Tauriello DV\"}, \"line\": 55197, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 68, \"target\": 11, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"The conserved cylindromatosis (CYLD) codes for a deubiquitinating enzyme and is a crucial regulator of diverse cellular processes such as immune responses, inflammation, death, and proliferation. It directly regulates multiple key signaling cascades, such as the Nuclear Factor kappa B [NF-kB] and the Mitogen-Activated Protein Kinase (MAPK) pathways, by its catalytic activity on polyubiquitinated key intermediates.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Current drug targets\", \"reference\": \"25342597\", \"authors\": [\"Mathis BJ\", \"Lai Y\", \"Qu C\", \"Janicki JS\", \"Cui T\"], \"date\": \"2015-01-01\", \"title\": \"CYLD-mediated signaling and diseases.\", \"lastauthor\": \"Cui T\", \"volume\": \"16\", \"issue\": \"4\", \"pages\": \"284-94\", \"firstauthor\": \"Mathis BJ\"}, \"line\": 55218, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 68, \"target\": 35, \"key\": 0}, {\"relation\": \"increases\", \"evidence\": \"This kinase acts as a positive regaulator of Wnt signaling in Drosophila and in other systems; and can phosphorylate Dsh directly.\", \"citation\": {\"type\": \"PubMed\", \"name\": \"Developmental cell\", \"reference\": \"15935773\", \"authors\": [\"Ossipova O\", \"Dhawan S\", \"Sokol S\", \"Green JB\"], \"date\": \"2005-06-01\", \"title\": \"Distinct PAR-1 proteins function in different branches of Wnt signaling during vertebrate development.\", \"lastauthor\": \"Green JB\", \"volume\": \"8\", \"issue\": \"6\", \"pages\": \"829-41\", \"firstauthor\": \"Ossipova O\"}, \"line\": 55208, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 69, \"target\": 35, \"key\": 0}, {\"relation\": \"decreases\", \"evidence\": \"We report here, that indirect activation of canonical Wnt/-catenin signaling using Bromoindirubin-30-Oxime (6-BIO), an inhibitor of glycogen synthase kinase-3, protects hippocampal neurons from amyloid- (A) oligomers with the concomitant blockade of neuronal apoptosis. More importantly, activation with Wnt-5a, a non-canonical Wnt ligand, results in the modulation of mitochondrial dynamics, preventing the changes induced by A oligomers (Ao) in mitochondrial fission-fusion dynamics and modulates Bcl-2 increases induced by oligomers\", \"citation\": {\"type\": \"PubMed\", \"name\": \"European journal of cell biology\", \"reference\": \"3691552\", \"authors\": [\"Mednieks MI\", \"Jungmann RA\", \"Hand AR\"], \"date\": \"1987-10-01\", \"title\": \"Ultrastructural immunocytochemical localization of cyclic AMP-dependent protein kinase regulatory subunits in rat parotid acinar cells.\", \"lastauthor\": \"Hand AR\", \"volume\": \"44\", \"issue\": \"2\", \"pages\": \"308-17\", \"firstauthor\": \"Mednieks MI\"}, \"line\": 55808, \"annotations\": {\"Subgraph\": \"Wnt signaling subgraph\"}, \"source\": 70, \"target\": 71, \"key\": 0}]};\n",
       "        const color_map = {'Protein': '#1F77B4', 'Pathology': '#FF7F0E', 'BiologicalProcess': '#2CA02C', 'miRNA': '#D62728', 'Complex': '#9467bd', 'Composite': '#9467bd', 'Reaction': '#8c564b', 'Gene': '#e377c2', 'Abundance': '#bcbd22', 'RNA': '#17becf'};\n",
       "    \n",
       "        require.config({\n",
       "          paths: {\n",
       "              d3: '//cdnjs.cloudflare.com/ajax/libs/d3/4.5.0/d3.min'\n",
       "          }\n",
       "        });\n",
       "\n",
       "        var elementInnerHTML = \"<div id='\" + chart + \"'></div>\";\n",
       "\n",
       "        element.append(elementInnerHTML);\n",
       "\n",
       "        var chartQualified = \"#\" + chart;\n",
       "\n",
       "        require(['d3'], function(d3) {\n",
       "            return init_d3_force(d3, graph, chartQualified, width, height, color_map);\n",
       "        });\n",
       "    "
      ],
      "text/plain": [
       "<IPython.core.display.Javascript object>"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import os\n",
    "\n",
    "from pybel import from_pickle\n",
    "from pybel_tools.selection import get_subgraph_by_annotation_value\n",
    "from pybel_tools.visualization import to_jupyter\n",
    "\n",
    "graph_path = os.path.expanduser('~/dev/bms/aetionomy/alzheimers/alzheimers.gpickle')\n",
    "\n",
    "graph = from_pickle(graph_path)\n",
    "wnt_subgraph = get_subgraph_by_annotation_value(graph, annotation='Subgraph', value='Wnt signaling subgraph')\n",
    "to_jupyter(wnt_subgraph)"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
